Literatures

Primary Site >> Liver Cancer

Gene >> EGFR

1.
Journal:	Shi Yan Sheng Wu Xue Bao. 1989 Dec;22(4):445-53.
Title:	[EGFR expression and EGF stimulation of proliferation in human liver carcinoma cells].
Author:	Xu, Y H\|Jiang, W L\|Peng, S F
PMID:	2560604

2.
Journal:	J Hepatol. 1992 Mar;14(2-3):377-80.
Title:	c-erbB-2 oncogene expression in hepatocellular carcinoma and cholangiocarcinoma.
Author:	Collier, J D\|Guo, K\|Mathew, J\|May, F E\|Bennett, M K\|Corbett, I P\|Bassendine, M F\|Burt, A D
PMID:	1380026

3.
Journal:	Liver. 1993 Jun;13(3):151-5.
Title:	Expression of transforming growth factor alpha in human hepatocellular carcinoma.
Author:	Collier, J D\|Guo, K\|Gullick, W J\|Bassendine, M F\|Burt, A D
PMID:	8393123

4.
Journal:	J Gastroenterol. 1994 Oct;29(5):616-20.
Title:	Serum levels of c-erbB-2 protein in digestive diseases.
Author:	Motoo, Y\|Sawabu, N\|Yamaguchi, Y\|Mouri, I\|Yamakawa, O\|Watanabe, H\|Ohta, H\|Okai, T\|Makino, H
PMID:	7528080

5.
Journal:	Gan To Kagaku Ryoho. 1994 Jul;21(8):1245-53.
Title:	[Clinical study of serum ErbB-2 protein using sandwich radioimmunometric assay (ErbB-2 IRMA 'Eiken')].
Author:	Sugano, K\|Kawai, T\|Ishii, M\|Koyama, H\|Kitajima, M\|Kasumi, F\|Demura, R\|Nakayama, T\|Okabe, H\|Mori, S
PMID:	7913312

6.
Journal:	Carcinogenesis. 1995 Jan;16(1):77-82.
Title:	TGF alpha differentially expressed in liver foci induced by diethylnitrosamine initiation and peroxisome proliferator promotion.
Author:	Miller, R T\|Cattley, R C\|Marsman, D S\|Lyght, O\|Popp, J A
PMID:	7530605

7.
Journal:	Hum Pathol. 1995 Oct;26(10):1126-32.
Title:	Nodules of less-differentiated tumor within or adjacent to hepatocellular carcinoma: relative expression of transforming growth factor-alpha and its receptor in the different areas of tumor.
Author:	Morimitsu, Y\|Hsia, C C\|Kojiro, M\|Tabor, E
PMID:	7557946

8.
Journal:	Zhonghua Bing Li Xue Za Zhi. 1995 Apr;24(2):93-5.
Title:	[Expression of c-erbB-2 protein and EGF receptor in hepatitis B, cirrhosis and hepatocellular carcinoma].
Author:	Su, Q\|Liu, Y
PMID:	7788735

9.
Journal:	Shi Yan Sheng Wu Xue Bao. 1995 Sep;28(3):241-6.
Title:	[An EGFR antisense oligodeoxynucleotides and its phosphorothioate analogue inhibit the growth of human hepatocarcinoma BEL-7404 cells].
Author:	Lin, J Q\|Xu, Z S\|Zhang, H Y\|Yang, Z W\|Xu, Y H
PMID:	8571707

10.
Journal:	Cancer Lett. 1996 Apr 19;102(1-2):65-71.
Title:	Association of inhibition of cell growth by O-phospho-L-tyrosine with decreased tyrosine phosphorylation.
Author:	Mishra, S\|Hamburger, A W
PMID:	8603380

11.
Journal:	J Tongji Med Univ. 1996;16(1):6.
Title:	The relationship between mast cell infiltration and the expression of PCNA and EGFr in experimental hepatocellular carcinoma of liver and squamous cell carcinoma of stomach in rats.
Author:	Ruan, Y\|Wu, Z\|Ivankovic, S
PMID:	8758735

12.
Journal:	Hum Pathol. 1996 Aug;27(8):787-92.
Title:	Detection of transforming growth factor-alpha protein and messenger RNA in hepatobiliary diseases by immunohistochemical and in situ hybridization techniques.
Author:	Harada, K\|Terada, T\|Nakanuma, Y
PMID:	8760011

13.
Journal:	Cancer Lett. 1997 Jan 15;112(1):33-45.
Title:	Highly metastatic hepatocellular carcinomas induced in male F344 rats treated with N-nitrosomorpholine in combination with other hepatocarcinogens show a high incidence of p53 gene mutations along with altered mRNA expression of tumor-related genes.
Author:	Masui, T\|Nakanishi, H\|Inada, K\|Imai, T\|Mizoguchi, Y\|Yada, H\|Futakuchi, M\|Shirai, T\|Tatematsu, M
PMID:	9029167

14.
Journal:	Cancer Res. 1997 Apr 15;57(8):1510-5.
Title:	Improved targeting of an anti-epidermal growth factor receptor variant III monoclonal antibody in tumor xenografts after labeling using N-succinimidyl 5-iodo-3-pyridinecarboxylate.
Author:	Reist, C J\|Archer, G E\|Wikstrand, C J\|Bigner, D D\|Zalutsky, M R
PMID:	9108453

15.
Journal:	Toxicol Pathol. 1997 May-Jun;25(3):275-83.
Title:	Quantitative relationship between transforming growth factor-alpha and hepatic focal phenotype and progression in female mouse liver.
Author:	Moser, G J\|Wolf, D C\|Goldsworthy, T L
PMID:	9210259

16.
Journal:	Liver. 1997 Aug;17(4):177-82.
Title:	Expression of transforming growth factor alpha and epidermal growth factor receptor in human hepatocellular carcinoma.
Author:	Kira, S\|Nakanishi, T\|Suemori, S\|Kitamoto, M\|Watanabe, Y\|Kajiyama, G
PMID:	9298487

17.
Journal:	Clin Cancer Res. 1997 Jul;3(7):1059-66.
Title:	Analysis of transforming growth factor (TGF)-alpha/epidermal growth factor receptor, hepatocyte growth Factor/c-met,TGF-beta receptor type II, and p53 expression in human hepatocellular carcinomas.
Author:	Kiss, A\|Wang, N J\|Xie, J P\|Thorgeirsson, S S
PMID:	9815784

18.
Journal:	Zhonghua Zhong Liu Za Zhi. 1997 May;19(3):170-2.
Title:	[Alterations in metastatic properties of hepatocellular carcinoma cell following H-ras oncogene transfection].
Author:	Wang, Q\|Feng, X\|Lin, Z
PMID:	10920888

19.
Journal:	Int J Oncol. 1999 Mar;14(3):453-60.
Title:	Expressions of epidermal growth factor family and its receptor in hepatocellular carcinoma cell lines: relationship to cell proliferation.
Author:	Hisaka, T\|Yano, H\|Haramaki, M\|Utsunomiya, I\|Kojiro, M
PMID:	10024677

20.
Journal:	Liver. 1999 Aug;19(4):318-25.
Title:	Transforming growth factor-alpha and epidermal growth factor receptor in chronic liver disease and hepatocellular carcinoma.
Author:	Harada, K\|Shiota, G\|Kawasaki, H
PMID:	10459631

21.
Journal:	Int J Cancer. 2000 Feb 15;85(4):518-22.
Title:	Malignant transformation and EGFR activation of immortalized mouse liver epithelial cells caused by HBV enhancer-X from a human hepatocellular carcinoma.
Author:	Miyaki, M\|Sato, C\|Sakai, K\|Konishi, M\|Tanaka, K\|Muraoka, M\|Kikuchi-Yanoshita, R\|Nadaoka, Y\|Kanda, H\|Kitagawa, T
PMID:	10699924

22.
Journal:	Toxicol Appl Pharmacol. 2000 Jun 1;165(2):115-26.
Title:	EGF receptors of hepatocytes from rats treated with phenobarbital are sensitized to down-regulation by phenobarbital in culture.
Author:	Dalton, S R\|Jirtle, R L\|Meyer, S A
PMID:	10828207

23.
Journal:	Br J Cancer. 2001 May 18;84(10):1377-83.
Title:	Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma.
Author:	Ito, Y\|Takeda, T\|Sakon, M\|Tsujimoto, M\|Higashiyama, S\|Noda, K\|Miyoshi, E\|Monden, M\|Matsuura, N
PMID:	11355950

24.
Journal:	Electrophoresis. 2001 Aug;22(14):3001-8.
Title:	Proteome alterations in human hepatoma cells transfected with antisense epidermal growth factor receptor sequence.
Author:	Yu, L R\|Shao, X X\|Jiang, W L\|Xu, D\|Chang, Y C\|Xu, Y H\|Xia, Q C
PMID:	11565794

25.
Journal:	J Cell Physiol. 2002 Dec;193(3):263-74.
Title:	K vitamins, PTP antagonism, and cell growth arrest.
Author:	Carr, Brian I\|Wang, Ziqiu\|Kar, Siddhartha
PMID:	12384979

26.
Journal:	J Clin Oncol. 2003 Feb 1;21(3):406-12.
Title:	Thymidylate synthase expression in hepatic tumors is a predictor of survival and progression in patients with resectable metastatic colorectal cancer.
Author:	Gonen, Mithat\|Hummer, Amanda\|Zervoudakis, Alice\|Sullivan, Deidre\|Fong, Yuman\|Banerjee, Debabrata\|Klimstra, David\|Cordon-Cardo, Carlos\|Bertino, Joseph\|Kemeny, Nancy
PMID:	12560427

27.
Journal:	World J Gastroenterol. 2003 Mar;9(3):463-7.
Title:	A novel HBV antisense RNA gene delivery system targeting hepatocellular carcinoma.
Author:	Ma, Chun-Hong\|Sun, Wen-Sheng\|Tian, Pei-Kun\|Gao, Li-Fen\|Liu, Su-Xia\|Wang, Xiao-Yan\|Zhang, Li-Ning\|Cao, Ying-Lin\|Han, Li-Hui\|Liang, Xiao-Hong
PMID:	12632498

28.
Journal:	Dig Liver Dis. 2003 May;35(5):332-8.
Title:	Investigation of ErbB1 and ErbB2 expression for therapeutic targeting in primary liver tumours.
Author:	Altimari, A\|Fiorentino, M\|Gabusi, E\|Gruppioni, E\|Corti, B\|D'Errico, A\|Grigioni, W F
PMID:	12846405

29.
Journal:	Toxicol Appl Pharmacol. 2003 Jul 15;190(2):135-45.
Title:	Expression of potential beta-catenin targets, cyclin D1, c-Jun, c-Myc, E-cadherin, and EGFR in chemically induced hepatocellular neoplasms from B6C3F1 mice.
Author:	Anna, Colleen H\|Iida, Mari\|Sills, Robert C\|Devereux, Theodora R
PMID:	12878043

30.
Journal:	Beijing Da Xue Xue Bao Yi Xue Ban. 2003 Aug;35(4):340-7.
Title:	[Identification and characterization of LAPTM4B encoded by a human hepatocellular carcinoma-associated novel gene].
Author:	Liu, Xinrong\|Zhou, Rouli\|Zhang, Qingyun\|Zhang, Ye\|Shao, Genze\|Jin, Yueying\|Zhang, Sha\|Lin, Ming\|Rui, Jing'an\|Ye, Daxiong
PMID:	12947545

31.
Journal:	Br J Cancer. 2004 Nov 29;91(11):1964-9.
Title:	Laminin-5 offsets the efficacy of gefitinib ('Iressa') in hepatocellular carcinoma cells.
Author:	Giannelli, G\|Azzariti, A\|Fransvea, E\|Porcelli, L\|Antonaci, S\|Paradiso, A
PMID:	15545972

32.
Journal:	J Hepatol. 2005 Oct;43(4):661-9.
Title:	Erlotinib induces cell cycle arrest and apoptosis in hepatocellular cancer cells and enhances chemosensitivity towards cytostatics.
Author:	Huether, Alexander\|Hopfner, Michael\|Sutter, Andreas P\|Schuppan, Detlef\|Scherubl, Hans
PMID:	16023762

33.
Journal:	Clin Exp Metastasis. 2005;22(2):137-47.
Title:	Establishment and characterization of three novel human gastric cancer cell lines with differentiated intestinal phenotype derived from liver metastasis.
Author:	Nakanishi, Hayao\|Yasui, Kenzo\|Ikehara, Yuzuru\|Yokoyama, Hiroyuki\|Munesue, Seiichi\|Kodera, Yasuhiro\|Tatematsu, Masae
PMID:	16086234

34.
Journal:	Biochem Pharmacol. 2006 Feb 14;71(4):479-85.
Title:	ZD6474 inhibits proliferation and invasion of human hepatocellular carcinoma cells.
Author:	Giannelli, Gianluigi\|Azzariti, Amalia\|Sgarra, Concetta\|Porcelli, Letizia\|Antonaci, Salvatore\|Paradiso, Angelo
PMID:	16332356

35.
Journal:	Cancer Treat Rev. 2006 Feb;32(1):28-44.
Title:	Cyclooxygenase-2 in hepatocellular carcinoma.
Author:	Wu, Tong
PMID:	16337744

36.
Journal:	Oncogene. 2006 Jun 26;25(27):3787-800.
Title:	Dysregulation of growth factor signaling in human hepatocellular carcinoma.
Author:	Breuhahn, K\|Longerich, T\|Schirmacher, P
PMID:	16799620

37.
Journal:	APMIS. 2006 Jun;114(6):420-7.
Title:	Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma.
Author:	El-Bassiouni, A\|Nosseir, M\|Zoheiry, M\|El-Ahwany, E\|Ghali, A\|El-Bassiouni, N
PMID:	16856963

38.
Journal:	World J Gastroenterol. 2006 Aug 28;12(32):5160-7.
Title:	Signaling pathways involved in the inhibition of epidermal growth factor receptor by erlotinib in hepatocellular cancer.
Author:	Huether, Alexander\|Hopfner, Michael\|Sutter, Andreas P\|Baradari, Viola\|Schuppan, Detlef\|Scherubl, Hans
PMID:	16937526

39.
Journal:	Hum Pathol. 2006 Oct;37(10):1324-32.
Title:	Expression of betacellulin and epidermal growth factor receptor in hepatocellular carcinoma: implications for angiogenesis.
Author:	Moon, Woo Sung\|Park, Ho Sung\|Yu, Ki Hoon\|Park, Min Young\|Kim, Kyung Ryoul\|Jang, Kyu Yun\|Kim, Jong Suk\|Cho, Baik Hwan
PMID:	16949929

40.
Journal:	BMC Cancer. 2006 Dec 6;6:278.
Title:	A novel mutation in the tyrosine kinase domain of ERBB2 in hepatocellular carcinoma.
Author:	Bekaii-Saab, Tanios\|Williams, Nita\|Plass, Christoph\|Calero, Miguel Villalona\|Eng, Charis
PMID:	17150109

41.
Journal:	J Cancer Res Clin Oncol. 2007 Mar;133(3):145-52.
Title:	Roles of EGFR-Stat3 signal pathway in carcinogenesis of experimental hepatoma in rats.
Author:	Yu, Xiao Tang\|Zhu, Shi Neng\|Xu, Zu De\|Hu, Xi Qi\|Zhu, Teng Fang\|Chen, Jie Qing\|Lu, Shi Lun
PMID:	17031671

42.
Journal:	Ann Surg Oncol. 2007 Feb;14(2):752-8.
Title:	COX-2 expression in hepatocellular carcinoma is an initiation event; while EGF receptor expression with downstream pathway activation is a prognostic predictor of survival.
Author:	Foster, Jason\|Black, Jennifer\|LeVea, Charles\|Khoury, Thaer\|Kuvshinoff, Boris\|Javle, Miland\|Gibbs, John F
PMID:	17146741

43.
Journal:	J Gastroenterol Hepatol. 2007 Mar;22(3):436-43.
Title:	Cimetidine inhibits epidermal growth factor-induced cell signaling.
Author:	Fujikawa, Tatsuya\|Shiraha, Hidenori\|Nakanishi, Yutaka\|Takaoka, Nobuyuki\|Ueda, Naoki\|Suzuki, Mayumi\|Shiratori, Yasushi
PMID:	17295779

44.
Journal:	Liver Int. 2007 Mar;27(2):174-85.
Title:	New molecular targets for hepatocellular carcinoma: the ErbB1 signaling system.
Author:	Berasain, Carmen\|Castillo, Josefa\|Prieto, Jesus\|Avila, Matias A
PMID:	17311611

45.
Journal:	Oncol Rep. 2007 Jul;18(1):279-85.
Title:	Anti-tumor effects of immunotherapeutic peptide on the treatment of hepatocellular carcinoma with HBc carrier.
Author:	Kong, Jing\|Diao, Zhenyu\|Deng, Xiaozhao\|Zhong, Hui\|Yao, Wenjuan\|Hu, Xuefang
PMID:	17549380

46.
Journal:	Hepatol Res. 2007 Nov;37(11):957-65.
Title:	Expression of Rab5a in hepatocellular carcinoma: Possible involvement in epidermal growth factor signaling.
Author:	Fukui, Koji\|Tamura, Shinji\|Wada, Akira\|Kamada, Yoshihiro\|Igura, Takumi\|Kiso, Shinichi\|Hayashi, Norio
PMID:	17581187

47.
Journal:	Gastroenterol Hepatol. 2007 Jun-Jul;30(6):360-9.
Title:	[Cell biology and genetics in liver cancer].
Author:	Tovar, Victoria\|Villanueva, Augusto\|Llovet, Josep M
PMID:	17662221

48.
Journal:	Hepatogastroenterology. 2007 Jul-Aug;54(77):1339-44.
Title:	Intestinal trefoil factor (TFF-3) and extracellular signal-regulated kinase (ERK) in cholangiocarcinoma.
Author:	Ailawadhi, Sikander\|Nagase, Hiroki\|Khoury, Thaer\|Yu, Jihnhee\|Tan, Dongfeng\|Black, Jennifer\|Brattain, Michael\|Javle, Milind
PMID:	17708250

49.
Journal:	Curr Pharm Des. 2007;13(32):3301-4.
Title:	Tyrosine kinase inhibitors: a potential approach to the treatment of hepatocellular carcinoma.
Author:	Giannelli, G\|Napoli, N\|Antonaci, S
PMID:	18045182

50.
Journal:	Transplantation. 2007 Nov 27;84(10):1262-71.
Title:	Angiogenesis soluble factors as hepatocellular carcinoma noninvasive markers for monitoring hepatitis C virus cirrhotic patients awaiting liver transplantation.
Author:	Mas, Valeria R\|Maluf, Daniel G\|Archer, Kellie J\|Yanek, Kenneth C\|Fisher, Robert A
PMID:	18049111

51.
Journal:	Gastrointest Cancer Res. 2007;1(4 Suppl 2):S13-21.
Title:	Liver stem cells and molecular signaling pathways in hepatocellular carcinoma.
Author:	Kitisin, Krit\|Pishvaian, Michael J\|Johnson, Lynt B\|Mishra, Lopa
PMID:	19360142

52.
Journal:	J Cancer Res Clin Oncol. 2008 Apr;134(4):503-13.
Title:	siRNA mediated the type 1 insulin-like growth factor receptor and epidermal growth factor receptor silencing induces chemosensitization of liver cancer cells.
Author:	Niu, Jian\|Li, Xiang-Nong\|Qian, Haixin\|Han, Zeguang
PMID:	17901981

53.
Journal:	J Hepatol. 2008 Jan;48(1):83-90.
Title:	Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection.
Author:	Schmitz, Klaus Juergen\|Wohlschlaeger, Jeremias\|Lang, Hauke\|Sotiropoulos, Georgios Charalambos\|Malago, Massimo\|Steveling, Karen\|Reis, Henning\|Cicinnati, Vito Rosario\|Schmid, Kurt Werner\|Baba, Hideo Andreas
PMID:	17998146

54.
Journal:	Bull Cancer. 2008 Jan;95(1):117-20.
Title:	[News in digestive oncology].
Author:	Michel, Pierre\|Di Fiore, Frederic
PMID:	18230577

55.
Journal:	Cancer Lett. 2008 Apr 18;262(2):257-64.
Title:	EGFR and VEGFR as potential target for biological therapies in HCC cells.
Author:	Giannelli, Gianluigi\|Sgarra, Concetta\|Porcelli, Letizia\|Azzariti, Amalia\|Antonaci, Salvatore\|Paradiso, Angelo
PMID:	18248788

56.
Journal:	Cancer. 2008 Jun 15;112(12):2733-9.
Title:	Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma: results of a multicenter phase 2 study.
Author:	Asnacios, Amani\|Fartoux, Laetitia\|Romano, Olivier\|Tesmoingt, Chloe\|Louafi S, Samy\|Mansoubakht, Touraj\|Artru, Pascal\|Poynard, Thierry\|Rosmorduc, Olivier\|Hebbar, Mohamed\|Taieb, Julien
PMID:	18412149

57.
Journal:	Hepatol Res. 2008 Aug;38(8):838-41.
Title:	Lack of somatic ErbB2 tyrosine kinase domain mutations in hepatocellular carcinoma.
Author:	Wong, Chiung-Ing\|Yap, Hui-Ling\|Lim, Seng-Gee\|Guo, Jia-Yi\|Goh, Boon-Cher\|Lee, Soo-Chin
PMID:	18462377

58.
Journal:	Hepatol Int. 2008 Jun;2(2):213-21.
Title:	Clinical impact of serum transforming growth factor-alpha mRNA as a predictive biomarker for the prognosis of fulminant hepatitis.
Author:	Miura, Norimasa\|Kabashima, Hiroko\|Shimizu, Mika\|Sato, Reina\|Tsukamoto, Tomoe\|Harada, Tomomi\|Takahashi, Shunsaku\|Endo, Ryujin\|Nakayama, Nobuaki\|Takikawa, Yasuhiro\|Mochida, Satoshi\|Suzuki, Kazuyuki\|Hasegawa, Junichi\|Shiota, Goshi
PMID:	19669307

59.
Journal:	Cancer Chemother Pharmacol. 2009 Sep;64(4):777-83.
Title:	A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer.
Author:	Ramanathan, Ramesh K\|Belani, Chandra P\|Singh, Deepti A\|Tanaka, Michael\|Lenz, Heinz-Josef\|Yen, Yun\|Kindler, Hedy L\|Iqbal, Syma\|Longmate, Jeff\|Mack, Philip C\|Lurje, Georg\|Gandour-Edwards, Regina\|Dancey, Janet\|Gandara, David R
PMID:	19169683

60.
Journal:	Cancer Lett. 2009 Jun 28;279(1):30-8.
Title:	Epidermal growth factor receptor vIII enhances tumorigenicity and resistance to 5-fluorouracil in human hepatocellular carcinoma.
Author:	Wang, Huamao\|Jiang, Hua\|Zhou, Min\|Xu, Zhibing\|Liu, Shiguo\|Shi, Bizhi\|Yao, Xiao\|Yao, Ming\|Gu, JianRen\|Li, Zonghai
PMID:	19217205

61.
Journal:	Nat Biotechnol. 2009 Mar;27(3):264-74.
Title:	A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinoma.
Author:	Keng, Vincent W\|Villanueva, Augusto\|Chiang, Derek Y\|Dupuy, Adam J\|Ryan, Barbara J\|Matise, Ilze\|Silverstein, Kevin A T\|Sarver, Aaron\|Starr, Timothy K\|Akagi, Keiko\|Tessarollo, Lino\|Collier, Lara S\|Powers, Scott\|Lowe, Scott W\|Jenkins, Nancy A\|Copeland, Neal
PMID:	19234449

62.
Journal:	J Hematol Oncol. 2009 Feb 23;2:9.
Title:	Updates in Gastrointestinal Oncology - insights from the 2008 44th annual meeting of the American Society of Clinical Oncology.
Author:	Javle, Milind\|Hsueh, Chung-Tsen
PMID:	19236713

63.
Journal:	Ann N Y Acad Sci. 2009 Feb;1155:187-93.
Title:	Aromatase in nontumoral and malignant human liver tissues and cells.
Author:	Carruba, Giuseppe
PMID:	19250204

64.
Journal:	Rev Med Interne. 2009 May;30(5):416-24.
Title:	[Targeted therapies and their indications in solid neoplasias].
Author:	Dreyer, C\|Raymond, E\|Faivre, S
PMID:	19299048

65.
Journal:	Cancer Res. 2009 May 1;69(9):4059-66.
Title:	Identification of potential driver genes in human liver carcinoma by genomewide screening.
Author:	Woo, Hyun Goo\|Park, Eun Sung\|Lee, Ju-Seog\|Lee, Yun-Han\|Ishikawa, Tsuyoshi\|Kim, Yoon Jun\|Thorgeirsson, Snorri S
PMID:	19366792

66.
Journal:	Bull Cancer. 2009 May;96(5):553-61.
Title:	[Targeted therapies in hepatocellular carcinomas: recent results and future development].
Author:	Marijon, H\|Faivre, S\|Raymond, E
PMID:	19467986

67.
Journal:	Ecotoxicology. 2009 Aug;18(6):715-21.
Title:	Transcriptional toxicity of the Yangtze River source water on mouse (Mus musculus) detected by cDNA microarray.
Author:	Wu, Bing\|Cheng, Shupei\|Li, Yiqiang\|Kong, Jie\|Zhao, Dayong\|Zhang, Yan\|Zhang, Xuxiang
PMID:	19499331

68.
Journal:	Gan To Kagaku Ryoho. 2009 Jun;36(6):1003-6.
Title:	[Two cases of KRAS wild-type unresectable or recurrent colorectal cancer effectively treated by cetuximab after progression of prior chemotherapy].
Author:	Yoda, Yusuke\|Yoshino, Takayuki\|Kadowaki, Shigenori\|Bando, Hideaki\|Okano, Susumu\|Fukushima, Hiraku\|Fuse, Nozomu\|Tahara, Makoto\|Doi, Toshihiko\|Ohtsu, Atsushi
PMID:	19542725

69.
Journal:	Clin Cancer Res. 2009 Sep 15;15(18):5895-901.
Title:	A multi-institutional phase II study of the efficacy and tolerability of lapatinib in patients with advanced hepatocellular carcinomas.
Author:	Bekaii-Saab, Tanios\|Markowitz, Joseph\|Prescott, Nichole\|Sadee, Wolfgang\|Heerema, Nyla\|Wei, Lai\|Dai, Zunyan\|Papp, Audrey\|Campbell, Angela\|Culler, Kristy\|Balint, Catherine\|O'Neil, Bert\|Lee, Ruey-Min\|Zalupski, Mark\|Dancey, Janet\|Chen, Helen\|Grever, Michael\|E
PMID:	19737952

70.
Journal:	Pathobiology. 2009;76(5):267-73.
Title:	Antisense phosphorothioate oligodeoxynucleic acid for CD10 suppresses liver metastasis of colorectal cancer.
Author:	Luo, Yi\|Fujii, Kiyomu\|Ohmori, Hitoshi\|Sasahira, Tomonori\|Moriwaka, Yukiko\|Isobe, Mamoru\|Kuniyasu, Hiroki
PMID:	19816087

71.
Journal:	J Mater Sci Mater Med. 2010 Feb;21(2):551-6.
Title:	Preparation of EGFR monoclonal antibody conjugated nanoparticles and targeting to hepatocellular carcinoma.
Author:	Liu, Peifeng\|Li, Zonghai\|Zhu, Mingjie\|Sun, Ying\|Li, Yaogang\|Wang, Hongzhi\|Duan, Yourong
PMID:	19921404

72.
Journal:	Oncol Rep. 2010 Jan;23(1):151-7.
Title:	The mitogenic effectors of isoproterenol in human hepatocellular carcinoma cells.
Author:	Yuan, Aihua\|Li, Zongfang\|Li, Xinqiu\|Yi, Shanyong\|Wang, Shukui\|Cai, Yongdong\|Cao, Hongyong
PMID:	19956875

73.
Journal:	J Endocrinol. 2010 Mar;204(3):299-309.
Title:	GH modulates hepatic epidermal growth factor signaling in the mouse.
Author:	Gonzalez, Lorena\|Diaz, Ma Eugenia\|Miquet, Johanna G\|Sotelo, Ana I\|Fernandez, Diego\|Dominici, Fernando P\|Bartke, Andrzej\|Turyn, Daniel
PMID:	20032199

74.
Journal:	Bioorg Med Chem. 2010 Feb;18(3):1117-23.
Title:	Design, synthesis and biological evaluation of chrysin long-chain derivatives as potential anticancer agents.
Author:	Lv, Peng-Cheng\|Wang, Kai-Rui\|Li, Qing-Shan\|Chen, Jin\|Sun, Juan\|Zhu, Hai-Liang
PMID:	20056425

75.
Journal:	Arch Toxicol. 2010 Feb;84(2):155-64.
Title:	Elevation of cell proliferation via generation of reactive oxygen species by piperonyl butoxide contributes to its liver tumor-promoting effects in mice.
Author:	Kawai, Masaomi\|Saegusa, Yukie\|Dewa, Yasuaki\|Nishimura, Jihei\|Kemmochi, Sayaka\|Harada, Tomoaki\|Ishii, Yuji\|Umemura, Takashi\|Shibutani, Makoto\|Mitsumori, Kunitoshi
PMID:	20101389

76.
Journal:	Am J Transl Res. 2010 Jan 23;2(1):105-18.
Title:	Molecular genetics of hepatocellular neoplasia.
Author:	Jain, Shilpa\|Singhal, Shashideep\|Lee, Peng\|Xu, Ruliang
PMID:	20182587

77.
Journal:	Eur J Med Chem. 2010 Jul;45(7):3184-90.
Title:	Synthesis and antiproliferative activity of indolizine derivatives incorporating a cyclopropylcarbonyl group against Hep-G2 cancer cell line.
Author:	Shen, Yong-Miao\|Lv, Peng-Cheng\|Chen, Wu\|Liu, Peng-Gang\|Zhang, Ming-Zhu\|Zhu, Hai-Liang
PMID:	20304535

78.
Journal:	Expert Opin Investig Drugs. 2010 May;19(5):663-72.
Title:	Beyond sorafenib: novel targeted therapies for advanced hepatocellular carcinoma.
Author:	Zhu, Andrew X
PMID:	20367287

79.
Journal:	Onkologie. 2010;33(5):263-9.
Title:	Hepatoid adenocarcinoma - review of the literature illustrated by a rare case originating in the peritoneal cavity.
Author:	Metzgeroth, Georgia\|Strobel, Philipp\|Baumbusch, Tobias\|Reiter, Andreas\|Hastka, Jan
PMID:	20502062

80.
Journal:	Oncol Rep. 2010 Aug;24(2):441-8.
Title:	Gastrin-releasing peptide promotes the growth of HepG2 cells via EGFR-independent ERK1/2 activation.
Author:	Li, Xinqiu\|Lv, Yunfu\|Yuan, Aihua\|Yi, Shanyong\|Ma, Yong\|Li, Zongfang
PMID:	20596631

81.
Journal:	Hepatology. 2010 Sep;52(3):975-86.
Title:	Preclinical assessment of simultaneous targeting of epidermal growth factor receptor (ErbB1) and ErbB2 as a strategy for cholangiocarcinoma therapy.
Author:	Zhang, Zichen\|Oyesanya, Regina A\|Campbell, Deanna J W\|Almenara, Jorge A\|Dewitt, Jennifer L\|Sirica, Alphonse E
PMID:	20607690

82.
Journal:	BMC Gastroenterol. 2010 Jul 9;10:79.
Title:	Mouse model of carbon tetrachloride induced liver fibrosis: Histopathological changes and expression of CD133 and epidermal growth factor.
Author:	Fujii, Tsutomu\|Fuchs, Bryan C\|Yamada, Suguru\|Lauwers, Gregory Y\|Kulu, Yakup\|Goodwin, Jonathan M\|Lanuti, Michael\|Tanabe, Kenneth K
PMID:	20618941

83.
Journal:	Cancer Lett. 2011 Feb 1;301(1):47-56.
Title:	Inhibition of poly (ADP-ribose) polymerase-1 enhances doxorubicin activity against liver cancer cells.
Author:	Munoz-Gamez, J A\|Quiles-Perez, R\|Ruiz-Extremera, A\|Martin-Alvarez, A B\|Sanjuan-Nunez, Laura\|Carazo, A\|Leon, Josefa\|Oliver, F J\|Salmeron, J
PMID:	21093979

84.
Journal:	Front Biosci (Schol Ed). 2011 Jan 1;3:16-22.
Title:	Targeting EGFR in bilio-pancreatic and liver carcinoma.
Author:	Fratto, Maria Elisabetta\|Santini, Daniele\|Vincenzi, Bruno\|Silvestris, Nicola\|Azzariti, Amalia\|Tommasi, Stefania\|Zoccoli, Alice\|Galluzzo, Sara\|Maiello, Evaristo\|Colucci, Giuseppe\|Tonini, Giuseppe
PMID:	21196353

85.
Journal:	Eur J Pharm Sci. 2011 Mar 18;42(4):387-91.
Title:	Combinational RNAi gene therapy of hepatocellular carcinoma by targeting human EGFR and TERT.
Author:	Hu, Yurong\|Shen, Yingying\|Ji, Baofang\|Wang, Lei\|Zhang, Zhenzhong\|Zhang, Yun
PMID:	21238587

86.
Journal:	Biochem Pharmacol. 2011 Apr 1;81(7):917-24.
Title:	The NADPH oxidase inhibitor VAS2870 impairs cell growth and enhances TGF-beta-induced apoptosis of liver tumor cells.
Author:	Sancho, Patricia\|Fabregat, Isabel
PMID:	21276422

87.
Journal:	Alcohol Clin Exp Res. 2011 May;35(5):821-5.
Title:	Molecular pathogenesis of hepatocellular carcinoma.
Author:	Cornella, Helena\|Alsinet, Clara\|Villanueva, Augusto
PMID:	21303380

88.
Journal:	J Cell Physiol. 2011 Jul;226(7):1934-9.
Title:	Oncosuppressor methylation: a possible key role in colon metastatic progression.
Author:	Tommasi, Stefania\|Pinto, Rosamaria\|Petriella, Daniela\|Pilato, Brunella\|Lacalamita, Rosanna\|Santini, Daniele\|Zito, Francesco\|Colucci, Giuseppe\|Paradiso, Angelo\|Silvestris, Nicola
PMID:	21506124

89.
Journal:	Cancer Res. 2011 Jun 1;71(11):4028-39.
Title:	EZH2-mediated concordant repression of Wnt antagonists promotes beta-catenin-dependent hepatocarcinogenesis.
Author:	Cheng, Alfred S L\|Lau, Suki S\|Chen, Yangchao\|Kondo, Yutaka\|Li, May S\|Feng, Hai\|Ching, Arthur K\|Cheung, Kin F\|Wong, Hoi K\|Tong, Joanna H\|Jin, Hongchuan\|Choy, Kwong W\|Yu, Jun\|To, Ka F\|Wong, Nathalie\|Huang, Tim H-M\|Sung, Joseph J Y
PMID:	21512140

90.
Journal:	Semin Liver Dis. 2011 May;31(2):173-87.
Title:	Genetics of hepatobiliary carcinogenesis.
Author:	Nault, Jean-Charles\|Zucman-Rossi, Jessica
PMID:	21538283

91.
Journal:	Hepatology. 2011 Sep 2;54(3):1031-42.
Title:	Human hepatic cancer stem cells are characterized by common stemness traits and diverse oncogenic pathways.
Author:	Marquardt, Jens U\|Raggi, Chiara\|Andersen, Jesper B\|Seo, Daekwan\|Avital, Itzhak\|Geller, David\|Lee, Yun-Han\|Kitade, Mitsuteru\|Holczbauer, Agnes\|Gillen, Matthew C\|Conner, Elizabeth A\|Factor, Valentina M\|Thorgeirsson, Snorri S
PMID:	21618577

92.
Journal:	Biochem J. 2011 Sep 1;438(2):349-58.
Title:	Suppression of TG-interacting factor sensitizes arsenic trioxide-induced apoptosis in human hepatocellular carcinoma cells.
Author:	Liu, Zi-Miao\|Tseng, Joseph T\|Hong, Duang-Yang\|Huang, Huei-Sheng
PMID:	21649584

93.
Journal:	Pathobiology. 2011;78(2):76-89.
Title:	Changing pathology with changing drugs: tumors of the gastrointestinal tract.
Author:	Cervera, Pascale\|Flejou, Jean-Francois
PMID:	21677471

94.
Journal:	Liver Transpl. 2011 Nov;17(11):1292-8.
Title:	Renal function in patients undergoing transplantation for nonalcoholic steatohepatitis cirrhosis: time to reconsider immunosuppression regimens?
Author:	Houlihan, Diarmaid D\|Armstrong, Matthew J\|Davidov, Yana\|Hodson, James\|Nightingale, Peter\|Rowe, Ian A\|Paris, Sue\|Gunson, Bridget K\|Bramhall, Simon B\|Mutimer, David J\|Neuberger, James M\|Newsome, Philip N
PMID:	21761549

95.
Journal:	Dig Dis. 2011;29(3):273-7.
Title:	Molecular targeted therapy for hepatocellular carcinoma: bench to bedside.
Author:	Kudo, Masatoshi
PMID:	21829017

96.
Journal:	Biochem Pharmacol. 2011 Dec 1;82(11):1583-92.
Title:	The tyrphostin AG1478 inhibits proliferation and induces death of liver tumor cells through EGF receptor-dependent and independent mechanisms.
Author:	Caja, Laia\|Sancho, Patricia\|Bertran, Esther\|Ortiz, Conrad\|Campbell, Jean S\|Fausto, Nelson\|Fabregat, Isabel
PMID:	21864510

97.
Journal:	Cancer Cell Int. 2011 Nov 17;11:40.
Title:	Involvement of the epidermal growth factor receptor in the modulation of multidrug resistance in human hepatocellular carcinoma cells in vitro.
Author:	Hoffmann, Katrin\|Xiao, Zhi\|Franz, Clemens\|Mohr, Elvira\|Serba, Susanne\|Buchler, Markus W\|Schemmer, Peter
PMID:	22088142

98.
Journal:	Anticancer Res. 2011 Nov;31(11):3883-90.
Title:	Correlation of gene expression of ATP-binding cassette protein and tyrosine kinase signaling pathway in patients with hepatocellular carcinoma.
Author:	Hoffmann, Katrin\|Shibo, Lin\|Xiao, Zhi\|Longerich, Thomas\|Buchler, Markus W\|Schemmer, Peter
PMID:	22110214

99.
Journal:	Gan To Kagaku Ryoho. 2011 Nov;38(12):2244-6.
Title:	[Three cases of patients in their eighties who received anti-EGFR antibody mono-therapy as first-line treatment for metastatic colorectal cancer].
Author:	Katsumoto, Yoshihiro\|Aritake, Noriko\|Endoh, Akira\|Ueda, Naoki\|Inami, Naokuni
PMID:	22202343

100.
Journal:	Biomaterials. 2012 Jan;33(1):270-82.
Title:	EGFR-specific PEGylated immunoliposomes for active siRNA delivery in hepatocellular carcinoma.
Author:	Gao, Jie\|Yu, Yongsheng\|Zhang, Yingying\|Song, Jinjing\|Chen, Huaiwen\|Li, Wei\|Qian, Weizhu\|Deng, Li\|Kou, Geng\|Chen, Jianming\|Guo, Yajun
PMID:	21963149

101.
Journal:	Arch Toxicol. 2012 Mar;86(3):497-507.
Title:	Mechanistic study on liver tumor promoting effects of flutamide in rats.
Author:	Tawfeeq, Mohammad Monir\|Hayashi, Hitomi\|Shimamoto, Keisuke\|Suzuki, Kazuhiko\|Shibutani, Makoto\|Inokuma, Hisashi\|Mitsumori, Kunitoshi
PMID:	22076107

102.
Journal:	Carcinogenesis. 2012 Jan;33(1):203-8.
Title:	Lignan transformation by gut bacteria lowers tumor burden in a gnotobiotic rat model of breast cancer.
Author:	Mabrok, Hoda B\|Klopfleisch, Robert\|Ghanem, Kadry Z\|Clavel, Thomas\|Blaut, Michael\|Loh, Gunnar
PMID:	22080573

103.
Journal:	Oncologist. 2012;17(1):13.
Title:	Phase II trial of erlotinib and docetaxel in advanced and refractory hepatocellular and biliary cancers: Hoosier Oncology Group GI06-101.
Author:	Chiorean, E Gabriela\|Ramasubbaiah, Rashmi\|Yu, Menggang\|Picus, Joel\|Bufill, Jose A\|Tong, Yan\|Coleman, Nicki\|Johnston, Erica L\|Currie, Colleen\|Loehrer, Patrick J
PMID:	22210086

104.
Journal:	Biochem J. 2012 May 1;443(3):691-700.
Title:	Cross-talk between TGFbeta1 and EGFR signalling pathways induces TM4SF5 expression and epithelial-mesenchymal transition.
Author:	Kang, Minkyung\|Choi, Suyong\|Jeong, Soo-Jin\|Lee, Sin-Ae\|Kwak, Tae Kyoung\|Kim, Hyeonjung\|Jung, Oisun\|Lee, Mi-Sook\|Ko, Youra\|Ryu, Jihye\|Choi, Yoon-Ju\|Jeong, Doyoung\|Lee, Hyo Jeong\|Ye, Sang-Kyu\|Kim, Sung-Hoon\|Lee, Jung Weon
PMID:	22292774

105.
Journal:	BMC Cancer. 2012 Mar 13;12:88.
Title:	Amphiregulin and Epiregulin mRNA expression in primary colorectal cancer and corresponding liver metastases.
Author:	Kuramochi, Hidekazu\|Nakajima, Go\|Kaneko, Yuka\|Nakamura, Ayako\|Inoue, Yuji\|Yamamoto, Masakazu\|Hayashi, Kazuhiko
PMID:	22409860

106.
Journal:	Zhonghua Liu Xing Bing Xue Za Zhi. 2012 Feb;33(2):215-9.
Title:	[Association of genetic polymorphisms of key molecules in JAK/STAT signaling pathway with susceptibility of hepatocellular carcinoma].
Author:	Xie, Jia-xin\|Yin, Jian-hua\|Zhang, Qi\|Pu, Rui\|Zhang, Yu-wei\|Lu, Wen-ying\|Cao, Guang-wen
PMID:	22575147

107.
Journal:	EMBO Mol Med. 2012 Aug;4(8):743-60.
Title:	DIAPH3 governs the cellular transition to the amoeboid tumour phenotype.
Author:	Hager, Martin H\|Morley, Samantha\|Bielenberg, Diane R\|Gao, Sizhen\|Morello, Matteo\|Holcomb, Ilona N\|Liu, Wennuan\|Mouneimne, Ghassan\|Demichelis, Francesca\|Kim, Jayoung\|Solomon, Keith R\|Adam, Rosalyn M\|Isaacs, William B\|Higgs, Henry N\|Vessella, Robert L\|Di Vi
PMID:	22593025

108.
Journal:	Curr Med Chem. 2012;19(22):3722-9.
Title:	Hepatocellular carcinoma: important biomarkers and their significance in molecular diagnostics and therapy.
Author:	Sengupta, B\|Siddiqi, S A
PMID:	22680921

109.
Journal:	Expert Opin Investig Drugs. 2012 Sep;21(9):1417-26.
Title:	Sorafenib in non-small cell lung cancer.
Author:	Zhang, Jianjun\|Gold, Kathryn A\|Kim, Edward
PMID:	22725255

110.
Journal:	Glycoconj J. 2012 Aug;29(5-6):411-24.
Title:	Surface glycoproteomic analysis of hepatocellular carcinoma cells by affinity enrichment and mass spectrometric identification.
Author:	Mi, Wei\|Jia, Wei\|Zheng, Zhaobin\|Wang, Jinglan\|Cai, Yun\|Ying, Wantao\|Qian, Xiaohong
PMID:	22752401

111.
Journal:	PLoS One. 2012;7(6):e39981.
Title:	Loss of the SxxSS motif in a human T-cell factor-4 isoform confers hypoxia resistance to liver cancer: an oncogenic switch in Wnt signaling.
Author:	Koga, Hironori\|Tsedensodnom, Orkhontuya\|Tomimaru, Yoshito\|Walker, Evan J\|Lee, Han Chu\|Kim, Kang Mo\|Yano, Hirohisa\|Wands, Jack R\|Kim, Miran
PMID:	22768190

112.
Journal:	PLoS One. 2012;7(7):e40638.
Title:	The transcription factor c-Jun protects against liver damage following activated beta-Catenin signaling.
Author:	Trierweiler, Claudia\|Blum, Hubert E\|Hasselblatt, Peter
PMID:	22792392

113.
Journal:	Asian Pac J Cancer Prev. 2012;13(4):1457-61.
Title:	HGFK1 is associated with a better prognosis and reverses inhibition by gefitinib in NSCLC cases.
Author:	Zhou, Xiao-Hui\|Tang, Li-Na\|Yue, Lu\|Min, Da-Liu\|Yang, Yi\|Huang, Jian-An\|Shen, Zan
PMID:	22799348

114.
Journal:	Asian Pac J Cancer Prev. 2012;13(5):2009-14.
Title:	Tas13D inhibits growth of SMMC-7721 cell via suppression VEGF and EGF expression.
Author:	He, Huai-Zhen\|Wang, Nan\|Zhang, Jie\|Zheng, Lei\|Zhang, Yan-Min
PMID:	22901163

115.
Journal:	Bioorg Med Chem. 2012 Oct 15;20(20):6144-53.
Title:	Development of erlotinib derivatives as CIP2A-ablating agents independent of EGFR activity.
Author:	Chen, Kuen-Feng\|Pao, Kuan-Chuan\|Su, Jung-Chen\|Chou, Yi-Chieh\|Liu, Chun-Yu\|Chen, Hui-Ju\|Huang, Jui-Wen\|Kim, InKi\|Shiau, Chung-Wai
PMID:	22980218

116.
Journal:	Biol Chem. 2012 Oct;393(10):1183-91.
Title:	Dual-specificity phosphatases are targets of the Wnt/beta-catenin pathway and candidate mediators of beta-catenin/Ras signaling interactions.
Author:	Zeller, Eva\|Mock, Katharina\|Horn, Moritz\|Colnot, Sabine\|Schwarz, Michael\|Braeuning, Albert
PMID:	23089536

117.
Journal:	Asian Pac J Cancer Prev. 2012;13(8):3967-71.
Title:	Multivariate analysis of molecular indicators for postoperative liver metastasis in colorectal cancer cases.
Author:	Qian, Li-Yuan\|Li, Ping\|Li, Xiao-Rong\|Chen, Dao-Jin\|Zhu, Shai-Hong
PMID:	23098501

118.
Journal:	Pathol Oncol Res. 2013 Jan;19(1):63-70.
Title:	Molecular characteristics of fibrolamellar hepatocellular carcinoma.
Author:	Patonai, Attila\|Erdelyi-Belle, Boglarka\|Korompay, Anna\|Somoracz, Aron\|Torzsok, Peter\|Kovalszky, Ilona\|Barbai, Tamas\|Raso, Erzsebet\|Lotz, Gabor\|Schaff, Zsuzsa\|Kiss, Andras
PMID:	22872444

119.
Journal:	Hepatology. 2013 Jan;57(1):120-30.
Title:	Sex bias occurrence of hepatocellular carcinoma in Poly7 molecular subclass is associated with EGFR.
Author:	Keng, Vincent W\|Sia, Daniela\|Sarver, Aaron L\|Tschida, Barbara R\|Fan, Danhua\|Alsinet, Clara\|Sole, Manel\|Lee, Wai L\|Kuka, Timothy P\|Moriarity, Branden S\|Villanueva, Augusto\|Dupuy, Adam J\|Riordan, Jesse D\|Bell, Jason B\|Silverstein, Kevin A T\|Llovet, Josep M\|
PMID:	22899566

120.
Journal:	Biochim Biophys Acta. 2013 Mar;1833(3):629-42.
Title:	The COOH-terminus of TM4SF5 in hepatoma cell lines regulates c-Src to form invasive protrusions via EGFR Tyr845 phosphorylation.
Author:	Jung, Oisun\|Choi, Yoon-Ju\|Kwak, Tae Kyoung\|Kang, Minkyung\|Lee, Mi-Sook\|Ryu, Jihye\|Kim, Hye-Jin\|Lee, Jung Weon
PMID:	23220047

121.
Journal:	Yonsei Med J. 2013 Jan 1;54(1):1-14.
Title:	The role of pharmacoethnicity in the development of cytotoxic and molecular targeted drugs in oncology.
Author:	Saijo, Nagahiro
PMID:	23225792

122.
Journal:	World J Gastroenterol. 2013 Feb 7;19(5):654-64.
Title:	Clinical impact of hepatitis B and C virus envelope glycoproteins.
Author:	Jeulin, Helene\|Velay, Aurelie\|Murray, John\|Schvoerer, Evelyne
PMID:	23429668

123.
Journal:	Int J Oncol. 2013 May;42(5):1833-41.
Title:	Prostaglandin E(2) receptor EP1-mediated phosphorylation of focal adhesion kinase enhances cell adhesion and migration in hepatocellular carcinoma cells.
Author:	Bai, Xiaoming\|Wang, Jie\|Zhang, Li\|Ma, Juan\|Zhang, Hai\|Xia, Shukai\|Zhang, Min\|Ma, Xiuping\|Guo, Yan\|Rong, Rong\|Cheng, Shanyu\|Shu, Wei\|Wang, Yipin\|Leng, Jing
PMID:	23525457

124.
Journal:	Am J Pathol. 2013 May;182(5):1648-58.
Title:	Role and regulation of PDGFRalpha signaling in liver development and regeneration.
Author:	Awuah, Prince K\|Nejak-Bowen, Kari N\|Monga, Satdarshan P S
PMID:	23529017

125.
Journal:	Oncol Rep. 2013 Jun;29(6):2211-8.
Title:	Cytohesin-2 as a novel prognostic marker for hepatocellular carcinoma.
Author:	Xu, Kedong\|Gao, Jie\|Yang, Xue\|Yao, Yingmin\|Liu, Qingguang
PMID:	23545718

126.
Journal:	Environ Sci Pollut Res Int. 2013 Sep;20(9):6468-81.
Title:	Signal transduction disturbance related to hepatocarcinogenesis in mouse by prolonged exposure to Nanjing drinking water.
Author:	Zhang, Rui\|Sun, Jie\|Zhang, Yan\|Cheng, Shupei\|Zhang, Xiaowei
PMID:	23591932

127.
Journal:	BMC Cancer. 2013 May 30;13:267.
Title:	Molecular mechanisms of action and potential biomarkers of growth inhibition of dasatinib (BMS-354825) on hepatocellular carcinoma cells.
Author:	Chang, Alex Y\|Wang, Miao
PMID:	23721490

128.
Journal:	PLoS One. 2013 Jun 13;8(6):e64260.
Title:	Actionable gene expression-based patient stratification for molecular targeted therapy in hepatocellular carcinoma.
Author:	Kwon, Jung-Hee\|Lee, Namgyu\|Park, Jin Young\|Yu, Yun Suk\|Kim, Jin Pyo\|Shin, Ji Hye\|Kim, Dong-Sik\|Joh, Jae Won\|Kim, Dae Shick\|Choi, Kwan Yong\|Kang, Koo-Jeong\|Kim, Gundo\|Moon, Young Ho\|Wang, Hee Jung
PMID:	23785399

129.
Journal:	Genet Test Mol Biomarkers. 2013 Aug;17(8):595-600.
Title:	Association of epidermal growth factor and epidermal growth factor receptor polymorphisms with the risk of hepatitis B virus-related hepatocellular carcinoma in the population of North China.
Author:	Wu, Jia\|Zhang, Wei\|Xu, Aiqiang\|Zhang, Li\|Yan, Tao\|Li, Zhuo\|Wu, Xiaopan\|Zhu, Xilin\|Ma, Juan\|Li, Ke\|Li, Hui\|Liu, Ying
PMID:	23790025

130.
Journal:	Cancer Biol Ther. 2013 Aug;14(8):703-10.
Title:	Off-label use of cetuximab plus sorafenib and panitumumab plus regorafenib to personalize therapy for a patient with V600E BRAF-mutant metastatic colon cancer.
Author:	Al-Marrawi, Mhd Yaser\|Saroya, Bikramajit Singh\|Brennan, Matthew C\|Yang, Zhaohai\|Dykes, Thomas M\|El-Deiry, Wafik S
PMID:	23792568

131.
Journal:	J BUON. 2013 Apr-Jun;18(2):477-85.
Title:	Triterpenoid pristimerin induced HepG2 cells apoptosis through ROS-mediated mitochondrial dysfunction.
Author:	Guo, Yan\|Zhang, Wei\|Yan, Yan-Yan\|Ma, Cun-Gen\|Wang, Xia\|Wang, Chen\|Zhao, Jia-Li
PMID:	23818365

132.
Journal:	Med Oncol. 2013;30(3):673.
Title:	Epidermal growth factor, its receptor and transforming growth factor-beta1 in the diagnosis of HCV-induced hepatocellular carcinoma.
Author:	Shehata, Fatma\|Abdel Monem, Nihad\|Sakr, Mohamed\|Kasem, Samar\|Balbaa, Mahmoud
PMID:	23912699

133.
Journal:	Gastroenterology. 2013 Dec;145(6):1436-48.e1-12.
Title:	MUC15 inhibits dimerization of EGFR and PI3K-AKT signaling and is associated with aggressive hepatocellular carcinomas in patients.
Author:	Wang, Ruo-Yu\|Chen, Lei\|Chen, Hai-Yang\|Hu, Liang\|Li, Liang\|Sun, Han-Yong\|Jiang, Feng\|Zhao, Jing\|Liu, Gao-Mi-Yang\|Tang, Jing\|Chen, Cai-Yang\|Yang, Ying-Cheng\|Chang, Yan-Xin\|Liu, Hui\|Zhang, Jin\|Yang, Yuan\|Huang, Gang\|Shen, Feng\|Wu, Meng-Chao\|Zhou, Wei-Ping\|Wa
PMID:	23933603

134.
Journal:	Biomaterials. 2013 Dec;34(38):10084-98.
Title:	Inhibition of hepatocellular carcinoma growth using immunoliposomes for co-delivery of adriamycin and ribonucleotide reductase M2 siRNA.
Author:	Gao, Jie\|Chen, Huaiwen\|Yu, Yongsheng\|Song, Jinjing\|Song, Hao\|Su, Xiao\|Li, Wei\|Tong, Xin\|Qian, Weizhu\|Wang, Hao\|Dai, Jianxin\|Guo, Yajun
PMID:	24060417

135.
Journal:	BMC Cancer. 2013 Oct 2;13:448.
Title:	MicroRNA-302b suppresses cell proliferation by targeting EGFR in human hepatocellular carcinoma SMMC-7721 cells.
Author:	Wang, Lumin\|Yao, Jiayi\|Shi, Xin\|Hu, Lili\|Li, Zongfang\|Song, Tusheng\|Huang, Chen
PMID:	24083596

136.
Journal:	Biochem Pharmacol. 2013 Dec 15;86(12):1721-30.
Title:	Novel compound PS-101 exhibits selective inhibition in non-small-cell lung cancer cell by blocking the EGFR-driven antiapoptotic pathway.
Author:	Zhang, Guo-Hai\|Cai, Le-Jing\|Wang, Yan-Fei\|Zhou, Yuan-Hua\|An, Yun-Feng\|Liu, Yan-Cheng\|Peng, Yan\|Chen, Zhen-Feng\|Liang, Hong
PMID:	24161785

137.
Journal:	PLoS One. 2013 Nov 4;8(11):e78624.
Title:	iSubgraph: integrative genomics for subgroup discovery in hepatocellular carcinoma using graph mining and mixture models.
Author:	Ozdemir, Bahadir\|Abd-Almageed, Wael\|Roessler, Stephanie\|Wang, Xin Wei
PMID:	24223834

138.
Journal:	Liver Cancer. 2013 Aug;2(3-4):345-64.
Title:	Clinical trials in hepatocellular carcinoma: an update.
Author:	Shen, Ying-Chun\|Lin, Zhong-Zhe\|Hsu, Chih-Hung\|Hsu, Chiun\|Shao, Yu-Yun\|Cheng, Ann-Lii
PMID:	24400222

139.
Journal:	J Carcinog. 2013 Dec 31;12:22.
Title:	Targeted therapies in development for non-small cell lung cancer.
Author:	Reungwetwattana, Thanyanan\|Dy, Grace Kho
PMID:	24574860

140.
Journal:	Nanomedicine (Lond). 2014 Feb;9(2):279-93.
Title:	Polymer-lipid hybrid nanoparticles conjugated with anti-EGF receptor antibody for targeted drug delivery to hepatocellular carcinoma.
Author:	Gao, Jie\|Xia, Yu\|Chen, Huaiwen\|Yu, Yongsheng\|Song, Jinjing\|Li, Wei\|Qian, Weizhu\|Wang, Hao\|Dai, Jianxin\|Guo, Yajun
PMID:	23721168

141.
Journal:	Cancer Lett. 2014 Jan 1;342(1):113-20.
Title:	The monoclonal antibody CH12 augments 5-fluorouracil-induced growth suppression of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III.
Author:	Jiang, Hua\|Dong, Qiongna\|Luo, Xiaoying\|Shi, Bizhi\|Wang, Huamao\|Gao, Huiping\|Kong, Juan\|Zhang, Jiqin\|Li, Zonghai
PMID:	24007863

142.
Journal:	J Cell Mol Med. 2014 Feb;18(2):218-30.
Title:	The role of EGF-EGFR signalling pathway in hepatocellular carcinoma inflammatory microenvironment.
Author:	Huang, Peixin\|Xu, Xiaojing\|Wang, Lingyan\|Zhu, Bijun\|Wang, Xiangdong\|Xia, Jingling
PMID:	24268047

143.
Journal:	J Gastroenterol. 2014 Jan;49(1):9-23.
Title:	The EGFR signalling system in the liver: from hepatoprotection to hepatocarcinogenesis.
Author:	Berasain, Carmen\|Avila, Matias A
PMID:	24318021

144.
Journal:	Technol Cancer Res Treat. 2014 Aug;13(4):377-85.
Title:	Combination of cetuximab and rapamycin enhances the therapeutic efficacy in hepatocellular carcinoma.
Author:	Geng, J\|Li, X\|Lang, X\|Qiao, C\|Hu, M\|Yang, J\|Feng, J\|Lv, M
PMID:	24325131

145.
Journal:	Matrix Biol. 2014 Apr;35:194-205.
Title:	Decorin deficiency promotes hepatic carcinogenesis.
Author:	Horvath, Zsolt\|Kovalszky, Ilona\|Fullar, Alexandra\|Kiss, Katalin\|Schaff, Zsuzsa\|Iozzo, Renato V\|Baghy, Kornelia
PMID:	24361483

146.
Journal:	Int J Oncol. 2014 Mar;44(3):769-80.
Title:	Prostaglandin E2 promotes hepatocellular carcinoma cell invasion through upregulation of YB-1 protein expression.
Author:	Zhang, Hai\|Cheng, Shanyu\|Zhang, Min\|Ma, Xiuping\|Zhang, Li\|Wang, Yipin\|Rong, Rong\|Ma, Juan\|Xia, Shukai\|Du, Mingzhan\|Shi, Feng\|Wang, Jie\|Yang, Qinyi\|Bai, Xiaoming\|Leng, Jing
PMID:	24378923

147.
Journal:	J Hepatol. 2014 Jun;60(6):1225-34.
Title:	Monoamine oxidase A suppresses hepatocellular carcinoma metastasis by inhibiting the adrenergic system and its transactivation of EGFR signaling.
Author:	Li, Jun\|Yang, Xiao-Mei\|Wang, Ya-Hui\|Feng, Ming-Xuan\|Liu, Xiao-Jin\|Zhang, Yan-Li\|Huang, Shuo\|Wu, Zheng\|Xue, Feng\|Qin, Wen-Xin\|Gu, Jian-Ren\|Xia, Qiang\|Zhang, Zhi-Gang
PMID:	24607627

148.
Journal:	Oncol Rep. 2014 May;31(5):2099-106.
Title:	Prostaglandin E(2) receptor EP2 mediates Snail expression in hepatocellular carcinoma cells.
Author:	Cheng, Shan-Yu\|Zhang, Hai\|Zhang, Min\|Xia, Shu-Kai\|Bai, Xiao-Ming\|Zhang, Li\|Ma, Juan\|Rong, Rong\|Wang, Yi-Pin\|Du, Ming-Zhan\|Wang, Jie\|Chen, Meng\|Shi, Feng\|Yang, Qin-Yi\|Leng, Jing
PMID:	24626807

149.
Journal:	Nanomedicine. 2014 Aug;10(6):1121-30.
Title:	Gold nanoparticles and radiofrequency in experimental models for hepatocellular carcinoma.
Author:	Raoof, Mustafa\|Corr, Stuart J\|Zhu, Cihui\|Cisneros, Brandon T\|Kaluarachchi, Warna D\|Phounsavath, Sophia\|Wilson, Lon J\|Curley, Steven A
PMID:	24650884

150.
Journal:	Hepatology. 2014 Apr;59(4):1577-90.
Title:	Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma.
Author:	Fuchs, Bryan C\|Hoshida, Yujin\|Fujii, Tsutomu\|Wei, Lan\|Yamada, Suguru\|Lauwers, Gregory Y\|McGinn, Christopher M\|DePeralta, Danielle K\|Chen, Xintong\|Kuroda, Toshihiko\|Lanuti, Michael\|Schmitt, Anthony D\|Gupta, Supriya\|Crenshaw, Andrew\|Onofrio, Robert\|Taylor,
PMID:	24677197

151.
Journal:	PLoS One. 2014 Apr 1;9(4):e93469.
Title:	Lack of Matrilin-2 favors liver tumor development via Erk1/2 and GSK-3beta pathways in vivo.
Author:	Fullar, Alexandra\|Baghy, Kornelia\|Deak, Ferenc\|Peterfia, Balint\|Zsak, Yvonne\|Tatrai, Peter\|Schaff, Zsuzsa\|Dudas, Jozsef\|Kiss, Ibolya\|Kovalszky, Ilona
PMID:	24691449

152.
Journal:	Cancer Sci. 2014 Jun;105(6):646-50.
Title:	Impact of epidermal growth factor single-nucleotide polymorphism on recurrence of hepatocellular carcinoma after hepatectomy in patients with chronic hepatitis C virus infection.
Author:	Yoshiya, Shohei\|Fujimoto, Yukiko\|Bekki, Yuki\|Konishi, Hideyuki\|Yamashita, Yo-Ichi\|Ikegami, Toru\|Yoshizumi, Tomoharu\|Shirabe, Ken\|Oda, Yoshinao\|Maehara, Yoshihiko
PMID:	24703510

153.
Journal:	Asian Pac J Cancer Prev. 2014;15(5):1961-70.
Title:	PKM2 regulates hepatocellular carcinoma cell epithelial-mesenchymal transition and migration upon EGFR activation.
Author:	Fan, Fang-Tian\|Shen, Cun-Si\|Tao, Li\|Tian, Chao\|Liu, Zhao-Guo\|Zhu, Zhi-Jie\|Liu, Yu-Ping\|Pei, Chang-Song\|Wu, Hong-Yan\|Zhang, Lei\|Wang, Ai-Yun\|Zheng, Shi-Zhong\|Huang, Shi-Le\|Lu, Yin
PMID:	24716919

154.
Journal:	Cancer Growth Metastasis. 2014 Mar 23;7:1-8.
Title:	TGF-beta Mediated Crosstalk Between Malignant Hepatocyte and Tumor Microenvironment in Hepatocellular Carcinoma.
Author:	Gupta, Devendra Kumar\|Singh, Neetu\|Sahu, Dinesh Kumar
PMID:	24741325

155.
Journal:	Tumour Biol. 2014 Jul;35(7):7135-45.
Title:	Prostaglandin E2 accelerates invasion by upregulating Snail in hepatocellular carcinoma cells.
Author:	Zhang, Min\|Zhang, Hai\|Cheng, Shanyu\|Zhang, Dengcai\|Xu, Yan\|Bai, Xiaoming\|Xia, Shukai\|Zhang, Li\|Ma, Juan\|Du, Mingzhan\|Wang, Yipin\|Wang, Jie\|Chen, Meng\|Leng, Jing
PMID:	24760275

156.
Journal:	Asian Pac J Cancer Prev. 2014;15(7):3045-50.
Title:	Targeting EGFL7 expression through RNA interference suppresses renal cell carcinoma growth by inhibiting angiogenesis.
Author:	Xu, Han-Feng\|Chen, Lei\|Liu, Xian-Dong\|Zhan, Yun-Hong\|Zhang, Hui-Hui\|Li, Qing\|Wu, Bin
PMID:	24815445

157.
Journal:	Cancer Biomark. 2014;14(2-3):177-84.
Title:	The prognostic value of the Na(+)/ H(+) exchanger regulatory factor 1 (NHERF1) protein in cancer.
Author:	Saponaro, Concetta\|Malfettone, Andrea\|Dell'Endice, Teresa Stefania\|Brunetti, Anna Elisabetta\|Achimas-Cadariu, Patriciu\|Paradiso, Angelo\|Mangia, Anita
PMID:	24878819

158.
Journal:	Tumour Biol. 2014 Sep;35(9):8893-901.
Title:	Activated macrophages down-regulate expression of E-cadherin in hepatocellular carcinoma cells via NF-kappaB/Slug pathway.
Author:	Wang, Xianteng\|Wang, Hao\|Li, Guosheng\|Song, Yonghong\|Wang, Shurong\|Zhu, Faliang\|Guo, Chun\|Zhang, Lining\|Shi, Yongyu
PMID:	24894673

159.
Journal:	Biomed Res Int. 2014;2014:384121.
Title:	Synergistic effect of MiR-146a mimic and cetuximab on hepatocellular carcinoma cells.
Author:	Huang, Suning\|He, Rongquan\|Rong, Minhua\|Dang, Yiwu\|Chen, Gang
PMID:	24895573

160.
Journal:	Expert Rev Gastroenterol Hepatol. 2014 Nov;8(8):875-85.
Title:	The role of targeted therapy for gastrointestinal tumors.
Author:	Rolfo, Christian\|Bronte, Giuseppe\|Sortino, Giovanni\|Papadimitriou, Konstantinos\|Passiglia, Francesco\|Fiorentino, Eugenio\|Marogy, Ghada\|Russo, Antonio\|Peeters, Marc
PMID:	24957206

161.
Journal:	J BUON. 2014 Apr-Jun;19(2):412-8.
Title:	Celastrol enhanced the anticancer effect of lapatinib in human hepatocellular carcinoma cells in vitro.
Author:	Yan, Yan-yan\|Guo, Yan\|Zhang, Wei\|Ma, Cun-gen\|Zhang, Yan-xia\|Wang, Chen\|Wang, Hai-xia
PMID:	24965400

162.
Journal:	Bioorg Med Chem Lett. 2014 Sep 15;24(18):4472-4476.
Title:	Design, synthesis and molecular modeling of biquinoline-pyridine hybrids as a new class of potential EGFR and HER-2 kinase inhibitors.
Author:	Sangani, Chetan B\|Makawana, Jigar A\|Duan, Yong-Tao\|Yin, Yong\|Teraiya, Shashikant B\|Thumar, Nilesh J\|Zhu, Hai-Liang
PMID:	25172421

163.
Journal:	Asian Pac J Cancer Prev. 2014;15(19):8069-73.
Title:	Crosstalk between EGFR and p53 in hepatocellular carcinoma.
Author:	Cioca, Andreea\|Cimpean, Anca\|Ceausu, Raluca\|Fit, Ana-Maria\|Zaharie, Teodor\|Al-Hajjar, Nadim\|Puia, Vlad\|Raica, Marius
PMID:	25338986

164.
Journal:	Front Endocrinol (Lausanne). 2014 Dec 18;5:218.
Title:	Evolution of hepatic steatosis to fibrosis and adenoma formation in liver-specific growth hormone receptor knockout mice.
Author:	Fan, Yong\|Fang, Xin\|Tajima, Asako\|Geng, Xuehui\|Ranganathan, Sarangarajan\|Dong, Henry\|Trucco, Massimo\|Sperling, Mark A
PMID:	25566190

165.
Journal:	Liver Int. 2015 Apr;35(4):1416-29.
Title:	Mannose-mediated inhibitory effects of PA-MSHA on invasion and metastasis of hepatocellular carcinoma via EGFR/Akt/IkappaBbeta/NF-kappaB pathway.
Author:	Li, Tao\|Dong, Zhao-Ru\|Guo, Zong-Yi\|Wang, Cheng-Hao\|Zhi, Xu-Ting\|Zhou, Jian-Wei\|Li, Deng-Ke\|Chen, Ze-Ting\|Chen, Zhi-Qiang\|Hu, San-Yuan
PMID:	25066210

166.
Journal:	Hepatology. 2015 Feb;61(2):613-26.
Title:	Growth hormone resistance exacerbates cholestasis-induced murine liver fibrosis.
Author:	Stiedl, Patricia\|McMahon, Robert\|Blaas, Leander\|Stanek, Victoria\|Svinka, Jasmin\|Grabner, Beatrice\|Zollner, Gernot\|Kessler, Sonja M\|Claudel, Thierry\|Muller, Mathias\|Mikulits, Wolfgang\|Bilban, Martin\|Esterbauer, Harald\|Eferl, Robert\|Haybaeck, Johannes\|Traun
PMID:	25179284

167.
Journal:	Invest New Drugs. 2015 Feb;33(1):128-37.
Title:	A phase I and pharmacokinetic study of ganetespib (STA-9090) in advanced hepatocellular carcinoma.
Author:	Goyal, Lipika\|Wadlow, Raymond C\|Blaszkowsky, Lawrence S\|Wolpin, Brian M\|Abrams, Thomas A\|McCleary, Nadine Jackson\|Sheehan, Susan\|Sundaram, Eamala\|Karol, Michael D\|Chen, John\|Zhu, Andrew X
PMID:	25248753

168.
Journal:	Mol Med Rep. 2015 Jan;11(1):712-8.
Title:	Reactive oxygen species-mediated activation of the Src-epidermal growth factor receptor-Akt signaling cascade prevents bortezomib-induced apoptosis in hepatocellular carcinoma cells.
Author:	Hou, Jinlin\|Cui, Anguo\|Song, Peiying\|Hua, Hui\|Luo, Ting\|Jiang, Yangfu
PMID:	25338626

169.
Journal:	Oncotarget. 2015 Feb 10;6(4):2180-92.
Title:	gamma-H2AX promotes hepatocellular carcinoma angiogenesis via EGFR/HIF-1alpha/VEGF pathways under hypoxic condition.
Author:	Xiao, Heng\|Tong, Rongliang\|Ding, Chaofeng\|Lv, Zhen\|Du, Chengli\|Peng, Chuanhui\|Cheng, Shaobing\|Xie, Haiyang\|Zhou, Lin\|Wu, Jian\|Zheng, Shusen
PMID:	25537504

170.
Journal:	Am J Cancer Res. 2014 Dec 15;5(1):396-410. eCollection 2015.
Title:	Epidermal growth factor receptor pathway polymorphisms and the prognosis of hepatocellular carcinoma.
Author:	Wang, Wenjia\|Ma, Xiao-Pin\|Shi, Zhuqing\|Zhang, Pengyin\|Ding, Dong-Lin\|Huang, Hui-Xing\|Saiyin, Hexi Ge\|Chen, Tao-Yang\|Lu, Pei-Xin\|Wang, Neng-Jin\|Yu, Hongjie\|Sun, Jielin\|Zheng, S Lilly\|Yu, Long\|Xu, Jianfeng\|Jiang, De-Ke
PMID:	25628948

171.
Journal:	Discov Med. 2015 Jan;19(102):7-14.
Title:	Novel molecular targets for diagnosis and treatment of hepatocellular carcinoma.
Author:	Ma, Lifang\|Ji, Lijuan\|Yu, Yongchun\|Wang, Jiayi
PMID:	25636956

172.
Journal:	J Cell Physiol. 2015 Sep;230(9):2281-98.
Title:	Nexavar/Stivarga and viagra interact to kill tumor cells.
Author:	Tavallai, Mehrad\|Hamed, Hossein A\|Roberts, Jane L\|Cruickshanks, Nichola\|Chuckalovcak, John\|Poklepovic, Andrew\|Booth, Laurence\|Dent, Paul
PMID:	25704960

173.
Journal:	Oncotarget. 2015 Mar 20;6(8):5650-65.
Title:	Knockdown of GALNT1 suppresses malignant phenotype of hepatocellular carcinoma by suppressing EGFR signaling.
Author:	Huang, Miao-Juei\|Hu, Rey-Heng\|Chou, Chih-Hsing\|Hsu, Chia-Lang\|Liu, Ya-Wen\|Huang, John\|Hung, Ji-Shiang\|Lai, I-Rue\|Juan, Hsueh-Fen\|Yu, Sung-Liang\|Wu, Yao-Ming\|Huang, Min-Chuan
PMID:	25730904

174.
Journal:	Sci Rep. 2015 Mar 6;5:8812.
Title:	Amphiregulin activates human hepatic stellate cells and is upregulated in non alcoholic steatohepatitis.
Author:	McKee, Chad\|Sigala, Barbara\|Soeda, Junpei\|Mouralidarane, Angelina\|Morgan, Maelle\|Mazzoccoli, Gianluigi\|Rappa, Francesca\|Cappello, Francesco\|Cabibi, Daniela\|Pazienza, Valerio\|Selden, Claire\|Roskams, Tania\|Vinciguerra, Manlio\|Oben, Jude A
PMID:	25744849

175.
Journal:	Mol Med Rep. 2015 Jul;12(1):1421-8.
Title:	Enoyl-coenzyme A hydratase short chain 1 silencing attenuates the proliferation of hepatocellular carcinoma by inhibiting epidermal growth factor signaling in vitro and in vivo.
Author:	Lin, Bi-Yun\|Xiao, Chuan-Xing\|Zhao, Wen-Xiu\|Xiao, Li\|Chen, Xu\|Li, Ping\|Wang, Xiao-Min
PMID:	25760819

176.
Journal:	BMC Genomics. 2015 Feb 25;16:124.
Title:	Proteome mapping of epidermal growth factor induced hepatocellular carcinomas identifies novel cell metabolism targets and mitogen activated protein kinase signalling events.
Author:	Borlak, Jurgen\|Singh, Prashant\|Gazzana, Giuseppe
PMID:	25872475

177.
Journal:	J Gen Virol. 2015 Aug;96(8):2133-44.
Title:	Hepatitis C virus NS5A protein blocks epidermal growth factor receptor degradation via a proline motif- dependent interaction.
Author:	Igloi, Zsofia\|Kazlauskas, Arunas\|Saksela, Kalle\|Macdonald, Andrew\|Mankouri, Jamel\|Harris, Mark
PMID:	25872741

178.
Journal:	BMC Cancer. 2015 May 10;15:389.
Title:	The role of c-Src in the invasion and metastasis of hepatocellular carcinoma cells induced by association of cell surface GRP78 with activated alpha2M.
Author:	Zhao, Song\|Li, Hongdan\|Wang, Qingjun\|Su, Chang\|Wang, Guan\|Song, Huijuan\|Zhao, Liang\|Luan, Zhidong\|Su, Rongjian
PMID:	25958313

179.
Journal:	Best Pract Res Clin Gastroenterol. 2015 Apr;29(2):345-53.
Title:	Systemic therapy of cholangiocarcinoma: From chemotherapy to targeted therapies.
Author:	Schweitzer, N\|Vogel, A
PMID:	25966433

180.
Journal:	Am J Cancer Res. 2015 Jan 15;5(2):702-13. eCollection 2015.
Title:	Dynamin2 downregulation delays EGFR endocytic trafficking and promotes EGFR signaling and invasion in hepatocellular carcinoma.
Author:	Gong, Chaojie\|Zhang, Jubo\|Zhang, Lan\|Wang, Yingcong\|Ma, Hui\|Wu, Weizhong\|Cui, Jiefeng\|Wang, Yanhong\|Ren, Zhenggang
PMID:	25973308

181.
Journal:	Oncotarget. 2015 Jun 30;6(18):16507-16.
Title:	Nuclear EGFR impairs ASPP2-p53 complex-induced apoptosis by inducing SOS1 expression in hepatocellular carcinoma.
Author:	Liu, Kai\|Jiang, Tao\|Ouyang, Yabo\|Shi, Ying\|Zang, Yunjin\|Li, Ning\|Lu, Shichun\|Chen, Dexi
PMID:	25980493

182.
Journal:	PLoS One. 2015 May 22;10(5):e0128159.
Title:	The EGFR/ErbB3 Pathway Acts as a Compensatory Survival Mechanism upon c-Met Inhibition in Human c-Met+ Hepatocellular Carcinoma.
Author:	Steinway, Steven N\|Dang, Hien\|You, Hanning\|Rountree, C Bart\|Ding, Wei
PMID:	26000702

183.
Journal:	Genomics. 2015 Aug;106(2):71-5.
Title:	Discrepancies between the K-ras mutational status of primary colorectal cancers and corresponding liver metastases are found in codon 13.
Author:	Kawamata, Hiroshi\|Yamashita, Keishi\|Kojo, Ken\|Ushiku, Hideki\|Ooki, Akira\|Watanabe, Masahiko
PMID:	26026309

184.
Journal:	Discov Med. 2015 May;19(106):333-41.
Title:	Lower serum soluble-EGFR is a potential biomarker for metastasis of HCC demonstrated by N-glycoproteomic analysis.
Author:	Hu, Heng\|Gao, Lingling\|Wang, Cun\|Li, Yan\|Ma, Huiying\|Chen, Long\|Qin, Jie\|Liu, Binbin\|Liu, Yinkun\|Liang, Chunmin
PMID:	26105696

185.
Journal:	Cancer Sci. 2015 Sep;106(9):1143-52.
Title:	Inhibition of microRNA-214 ameliorates hepatic fibrosis and tumor incidence in platelet-derived growth factor C transgenic mice.
Author:	Okada, Hikari\|Honda, Masao\|Campbell, Jean S\|Takegoshi, Kai\|Sakai, Yoshio\|Yamashita, Taro\|Shirasaki, Takayoshi\|Takabatake, Riuta\|Nakamura, Mikiko\|Tanaka, Takuji\|Kaneko, Shuichi
PMID:	26122702

186.
Journal:	Nanomedicine (Lond). 2015 Jul;10(12):1863-79.
Title:	The promotion of salinomycin delivery to hepatocellular carcinoma cells through EGFR and CD133 aptamers conjugation by PLGA nanoparticles.
Author:	Jiang, Jianxin\|Chen, Huaiwen\|Yu, Chao\|Zhang, Yingying\|Chen, Meiyuan\|Tian, She\|Sun, Chengyi
PMID:	26139123

187.
Journal:	PLoS One. 2015 Jul 6;10(7):e0132319.
Title:	Synergistic Induction of Potential Warburg Effect in Zebrafish Hepatocellular Carcinoma by Co-Transgenic Expression of Myc and xmrk Oncogenes.
Author:	Li, Zhen\|Zheng, Weiling\|Li, Hankun\|Li, Caixia\|Gong, Zhiyuan
PMID:	26147004

188.
Journal:	Pathol Res Pract. 2015 Sep;211(9):665-70.
Title:	Morphological aspects of the hepatic response to neoadjuvant therapy.
Author:	Fernandez-Acenero, M J\|Cortes-Guiral, D\|Munoz, L Estrada\|Martinez-Useros, J\|Pastor-Idoate, C
PMID:	26163186

189.
Journal:	PLoS One. 2015 Jul 29;10(7):e0133081.
Title:	BAI1-Associated Protein 2-Like 1 (BAIAP2L1) Is a Potential Biomarker in Ovarian Cancer.
Author:	Chao, Angel\|Tsai, Chia-Lung\|Jung, Shih-Ming\|Chuang, Wei-Chi\|Kao, Chieh\|Hsu, An\|Chen, Shun-Hua\|Lin, Chiao-Yun\|Lee, Yi-Chao\|Lee, Yun-Shien\|Wang, Tzu-Hao\|Wang, Hsin-Shih\|Lai, Chyong-Huey
PMID:	26222696

190.
Journal:	Anticancer Drugs. 2015 Oct;26(9):1004-7.
Title:	A significant response to sorafenib in a woman with advanced lung adenocarcinoma and a BRAF non-V600 mutation.
Author:	Sereno, Maria\|Moreno, Victor\|Moreno Rubio, Juan\|Gomez-Raposo, Cesar\|Garcia Sanchez, Sagrario\|Hernandez Jusdado, Rebeca\|Falagan, Sandra\|Zambrana Tebar, Francisco\|Casado Saenz, Enrique
PMID:	26237499

191.
Journal:	Cancer Lett. 2015 Nov 1;368(1):126-34.
Title:	Matrine derivative WM130 inhibits hepatocellular carcinoma by suppressing EGFR/ERK/MMP-2 and PTEN/AKT signaling pathways.
Author:	Qian, Liqiang\|Liu, Yan\|Xu, Yang\|Ji, Weidan\|Wu, Qiuye\|Liu, Yongjing\|Gao, Quangen\|Su, Changqing
PMID:	26259512

192.
Journal:	Asian Pac J Trop Med. 2015 Jul;8(7):560-4.
Title:	Anti-tumor effect of LTA combined with 5-FU on H22 tumor bearing mice.
Author:	Wang, Bin\|Lei, Chang-Jiang\|Wu, Rong\|Li, Lei\|Deng, Chun-Mei\|Chen, Wen-Xia\|Hu, Fu-Rong\|Long, Hao-Cheng\|Tao, Ze-Zhang\|Zeng, Cheng\|Huang, Jian-Bin\|Chen, Chun-Zhou\|Ren, De-Fa
PMID:	26276288

193.
Journal:	APMIS. 2015 Oct;123(10):823-31.
Title:	Impact of epidermal growth factor receptor and transforming growth factor-alpha on hepatitis C virus-induced hepatocarcinogenesis.
Author:	Badawy, Afkar Abdel-Ghany\|El-Hindawi, Ali\|Hammam, Olfat\|Moussa, Mona\|Gabal, Samia\|Said, Noha
PMID:	26279457

194.
Journal:	Chem Biol Interact. 2015 Dec 5;242:107-22.
Title:	Novel carbocyclic curcumin analog CUR3d modulates genes involved in multiple apoptosis pathways in human hepatocellular carcinoma cells.
Author:	Bhullar, Khushwant S\|Jha, Amitabh\|Rupasinghe, H P Vasantha
PMID:	26409325

195.
Journal:	Am J Physiol Gastrointest Liver Physiol. 2015 Dec 15;309(12):G942-54.
Title:	Loss of hepatocyte ERBB3 but not EGFR impairs hepatocarcinogenesis.
Author:	Scheving, Lawrence A\|Zhang, Xiuqi\|Stevenson, Mary C\|Weintraub, Michael A\|Abbasi, Annam\|Clarke, Andrea M\|Threadgill, David W\|Russell, William E
PMID:	26492920

196.
Journal:	PLoS One. 2015 Dec 4;10(12):e0143830.
Title:	Additive Anti-Tumor Effects of Lovastatin and Everolimus In Vitro through Simultaneous Inhibition of Signaling Pathways.
Author:	Nolting, Svenja\|Maurer, Julian\|Spottl, Gerald\|Aristizabal Prada, Elke Tatjana\|Reuther, Clemens\|Young, Karen\|Korbonits, Marta\|Goke, Burkhard\|Grossman, Ashley\|Auernhammer, Christoph J
PMID:	26636335

197.
Journal:	Rinsho Byori. 2015 Sep;63(9):1091-102.
Title:	[Alternative Splicing Detection as a Biomarker for Cancer Diagnosis: A Novel Progressive Mechanism of Acute Lymphoblastic Leukemia with Alternative Splicing as a Biomarker Candidate].
Author:	Kitamura, Kouichi\|Matsushita, Kazuyuki\|Kobayashi, Souhei\|Ishige, Takayuki\|Semba, Toshihisa\|Kimura, Asako\|Kazami, Takahiro\|Ohyama, Masayuki\|Itoga, Sakae\|Beppu, Minako\|Nishimura, Motoi\|Satoh, Mamoru\|Nomura, Fumio
PMID:	26731899

198.
Journal:	ACS Infect Dis. 2015 Sep 11;1(9):420-7.
Title:	Targeting Viral Entry for Treatment of Hepatitis B and C Virus Infections.
Author:	Colpitts, Che C\|Verrier, Eloi R\|Baumert, Thomas F
PMID:	27617925

199.
Journal:	Mol Carcinog. 2016 Jul;55(7):1138-49.
Title:	Amarogentin regulates self renewal pathways to restrict liver carcinogenesis in experimental mouse model.
Author:	Sur, Subhayan\|Pal, Debolina\|Banerjee, Kaustav\|Mandal, Suvra\|Das, Ashes\|Roy, Anup\|Panda, Chinmay Kumar
PMID:	26154024

200.
Journal:	Tumour Biol. 2016 Jan;37(1):1079-89.
Title:	The long noncoding RNA, EGFR-AS1, a target of GHR, increases the expression of EGFR in hepatocellular carcinoma.
Author:	Qi, Hao-Long\|Li, Chang-Sheng\|Qian, Chong-Wei\|Xiao, Yu-Sha\|Yuan, Yu-Feng\|Liu, Quan-Yan\|Liu, Zhi-Su
PMID:	26271667

201.
Journal:	Tumour Biol. 2016 Feb;37(2):2527-35.
Title:	Loss of protocadherin-17 (PCDH-17) promotes metastasis and invasion through hyperactivation of EGFR/MEK/ERK signaling pathway in hepatocellular carcinoma.
Author:	Dang, Zheng\|Shangguan, Jianying\|Zhang, Chao\|Hu, Peng\|Ren, Yanshun\|Lv, Zhicheng\|Xiang, Hongjun\|Wang, Xianghui
PMID:	26386721

202.
Journal:	J Nutr Biochem. 2016 Jan;27:32-42.
Title:	Tea polyphenols epigallocatechin gallete and theaflavin restrict mouse liver carcinogenesis through modulation of self-renewal Wnt and hedgehog pathways.
Author:	Sur, Subhayan\|Pal, Debolina\|Mandal, Syamsundar\|Roy, Anup\|Panda, Chinmay Kumar
PMID:	26386739

203.
Journal:	Oncotarget. 2016 Jan 5;7(1):266-78.
Title:	MicroRNA-107: a novel promoter of tumor progression that targets the CPEB3/EGFR axis in human hepatocellular carcinoma.
Author:	Zou, Chen-Dan\|Zhao, Wei-Ming\|Wang, Xiao-Na\|Li, Qiang\|Huang, Hui\|Cheng, Wan-Peng\|Jin, Jian-Feng\|Zhang, He\|Wu, Ming-Juan\|Tai, Sheng\|Zou, Chao-Xia\|Gao, Xu
PMID:	26497556

204.
Journal:	J Surg Oncol. 2016 Jan;113(1):55-61.
Title:	Comprehensive multiplatform biomarker analysis of 350 hepatocellular carcinomas identifies potential novel therapeutic options.
Author:	Ang, Celina\|Miura, John T\|Gamblin, T Clark\|He, Ruth\|Xiu, Joanne\|Millis, Sherri Z\|Gatalica, Zoran\|Reddy, Sandeep K\|Yee, Nelson S\|Abou-Alfa, Ghassan K
PMID:	26661118

205.
Journal:	Tumour Biol. 2016 Jul;37(7):9691-8.
Title:	Tumour-suppressive role of PTPN13 in hepatocellular carcinoma and its clinical significance.
Author:	Zhan, Hao\|Jiang, Jiahao\|Luo, Chubin\|Sun, Qiman\|Ke, Aiwu\|Sun, Chao\|Hu, Jinwu\|Hu, Zhiqiang\|Hu, Bo\|Zhu, Kai\|Fan, Jia\|Zhou, Jian\|Huang, Xiaowu
PMID:	26801674

206.
Journal:	J Cancer. 2016 Mar 20;7(6):671-80.
Title:	Sex Difference of Egfr Expression and Molecular Pathway in the Liver: Impact on Drug Design and Cancer Treatments?
Author:	Wang, Lishi\|Xiao, Jianqi\|Gu, Weikuan\|Chen, Hong
PMID:	27076848

207.
Journal:	Am J Transl Res. 2016 Apr 15;8(4):1799-812. eCollection 2016.
Title:	Genome-wide association study identified PLCE1- rs2797992 and EGFR- rs6950826 were associated with TP53 expression in the HBV-related hepatocellular carcinoma of Chinese patients in Guangxi.
Author:	Liao, Xiwen\|Han, Chuangye\|Qin, Wei\|Liu, Xiaoguang\|Yu, Long\|Lu, Sicong\|Chen, Zhiwei\|Zhu, Guangzhi\|Su, Hao\|Mo, Zengnan\|Qin, Xue\|Peng, Tao
PMID:	27186304

208.
Journal:	Oncotarget. 2016 Jun 28;7(26):39931-39944.
Title:	Screen-identified selective inhibitor of lysine demethylase 5A blocks cancer cell growth and drug resistance.
Author:	Gale, Molly\|Sayegh, Joyce\|Cao, Jian\|Norcia, Michael\|Gareiss, Peter\|Hoyer, Denton\|Merkel, Jane S\|Yan, Qin
PMID:	27224921

209.
Journal:	Oncotarget. 2016 Jul 19;7(29):45302-45316.
Title:	EGR1 mediates miR-203a suppress the hepatocellular carcinoma cells progression by targeting HOXD3 through EGFR signaling pathway.
Author:	Wang, Lumin\|Sun, Hongfei\|Wang, Xiaofei\|Hou, Ni\|Zhao, Lingyu\|Tong, Dongdong\|He, Kang\|Yang, Yang\|Song, Tusheng\|Yang, Jun\|Huang, Chen
PMID:	27244890

210.
Journal:	Cancer Res. 2016 Aug 15;76(16):4887-96.
Title:	(Z)-3,5,4'-Trimethoxystilbene Limits Hepatitis C and Cancer Pathophysiology by Blocking Microtubule Dynamics and Cell-Cycle Progression.
Author:	Nguyen, Charles B\|Kotturi, Hari\|Waris, Gulam\|Mohammed, Altaf\|Chandrakesan, Parthasarathy\|May, Randal\|Sureban, Sripathi\|Weygant, Nathaniel\|Qu, Dongfeng\|Rao, Chinthalapally V\|Dhanasekaran, Danny N\|Bronze, Michael S\|Houchen, Courtney W\|Ali, Naushad
PMID:	27287718

211.
Journal:	ACS Appl Mater Interfaces. 2016 Aug 3;8(30):19228-37.
Title:	iRGD-Decorated Polymeric Nanoparticles for the Efficient Delivery of Vandetanib to Hepatocellular Carcinoma: Preparation and in Vitro and in Vivo Evaluation.
Author:	Wang, Jianguo\|Wang, Hangxiang\|Li, Jie\|Liu, Zhikun\|Xie, Haiyang\|Wei, Xuyong\|Lu, Di\|Zhuang, Runzhou\|Xu, Xiao\|Zheng, Shusen
PMID:	27381493

212.
Journal:	Cell Biol Toxicol. 2016 Dec;32(6):499-511.
Title:	Actinidia chinensis Planch root extract (acRoots) inhibits hepatocellular carcinoma progression by inhibiting EP3 expression.
Author:	Fang, Tingting\|Hou, Jiayun\|He, Mingyan\|Wang, Lingyan\|Zheng, Minghuan\|Wang, Xiangdong\|Xia, Jinglin
PMID:	27475644

213.
Journal:	Sci Rep. 2016 Aug 9;6:31237.
Title:	EGFR and SYNE2 are associated with p21 expression and SYNE2 variants predict post-operative clinical outcomes in HBV-related hepatocellular carcinoma.
Author:	Han, Chuangye\|Liao, Xiwen\|Qin, Wei\|Yu, Long\|Liu, Xiaoguang\|Chen, Gang\|Liu, Zhengtao\|Lu, Sicong\|Chen, Zhiwei\|Su, Hao\|Zhu, Guangzhi\|Lu, Zili\|Liu, Zhiming\|Qin, Xue\|Gui, Ying\|Mo, Zengnan\|Li, Lequn\|Peng, Tao
PMID:	27502069

214.
Journal:	J Agric Food Chem. 2016 Sep 21;64(37):7002-13.
Title:	Repression of Human Hepatocellular Carcinoma Growth by Regulating Met/EGFR/VEGFR-Akt/NF-kappaB Pathways with Theanine and Its Derivative, (R)-2-(6,8-Dibromo-2-oxo-2H-chromene-3-carboxamido)-5-(ethylamino)-5-oxopentanoic Ethyl Ester (DTBrC).
Author:	Zhang, Guoying\|Li, Zheng\|Wan, Xiaochun\|Zhang, Ying\|Zhu, Rongqin\|Liu, Zhenzhen\|Ji, Dexin\|Zhang, Huarong\|Wu, Fei\|Tian, Huihui\|Liu, Kun\|Wu, Benhao
PMID:	27569455

215.
Journal:	Oncotarget. 2016 Nov 8;7(45):72908-72922.
Title:	Genomic characterization of liver metastases from colorectal cancer patients.
Author:	Sayagues, Jose Maria\|Corchete, Luis Antonio\|Gutierrez, Maria Laura\|Sarasquete, Maria Eugenia\|Del Mar Abad, Maria\|Bengoechea, Oscar\|Ferminan, Encarna\|Anduaga, Maria Fernanda\|Del Carmen, Sofia\|Iglesias, Manuel\|Esteban, Carmen\|Angoso, Maria\|Alcazar, Jose Ant
PMID:	27662660

216.
Journal:	Biomed Opt Express. 2016 Aug 1;7(9):3163-3169.
Title:	In vivo fluorescence imaging of hepatocellular carcinoma xenograft using near-infrared labeled epidermal growth factor receptor (EGFR) peptide.
Author:	Li, Z\|Zhou, Q\|Zhou, J\|Duan, X\|Zhu, J\|Wang, T D
PMID:	27699089

217.
Journal:	Photoacoustics. 2016 Apr 22;4(2):43-54.
Title:	In vivo photoacoustic tomography of EGFR overexpressed in hepatocellular carcinoma mouse xenograft.
Author:	Zhou, Quan\|Li, Zhao\|Zhou, Juan\|Joshi, Bishnu P\|Li, Gaoming\|Duan, Xiyu\|Kuick, Rork\|Owens, Scott R\|Wang, Thomas D
PMID:	27766208

218.
Journal:	Am J Transl Res. 2016 Nov 15;8(11):4670-4681. eCollection 2016.
Title:	eIF5A2 is an alternative pathway for cell proliferation in cetuximab-treated epithelial hepatocellular carcinoma.
Author:	Xue, Fei\|Liu, Yanhui\|Chu, Haoyuan\|Wen, Yu\|Yan, Lei\|Tang, Qiang\|Xiao, Erhui\|Zhang, Dongyi\|Zhang, Hongwei
PMID:	27904670

219.
Journal:	Abdom Radiol (NY). 2017 Feb;42(2):451-459.
Title:	Connecting cancer biology and clinical outcomes to imaging in KRAS mutant and wild-type colorectal cancer liver tumors following selective internal radiation therapy with yttrium-90.
Author:	Magnetta, Michael J\|Ghodadra, Anish\|Lahti, Steven J\|Xing, Minzhi\|Zhang, Di\|Kim, Hyun S
PMID:	27600383

220.
Journal:	Cancer Res. 2017 Jan 15;77(2):579-589.
Title:	SPINK6 Promotes Metastasis of Nasopharyngeal Carcinoma via Binding and Activation of Epithelial Growth Factor Receptor.
Author:	Zheng, Li-Sheng\|Yang, Jun-Ping\|Cao, Yun\|Peng, Li-Xia\|Sun, Rui\|Xie, Ping\|Wang, Meng-Yao\|Meng, Dong-Fang\|Luo, Dong-Hua\|Zou, Xiong\|Chen, Ming-Yuan\|Mai, Hai-Qiang\|Guo, Ling\|Guo, Xiang\|Shao, Jian-Yong\|Huang, Bi-Jun\|Zhang, Wei\|Qian, Chao-Nan
PMID:	27671677

221.
Journal:	Aliment Pharmacol Ther. 2017 Jan;45(1):150-159.
Title:	Do directly acting antiviral agents for HCV increase the risk of hepatic decompensation and decline in renal function? Results from ERCHIVES.
Author:	Butt, A A\|Ren, Y\|Marks, K\|Shaikh, O S\|Sherman, K E
PMID:	27813162

222.
Journal:	Mol Carcinog. 2017 Apr;56(4):1302-1311.
Title:	TGFbeta signaling confers sorafenib resistance via induction of multiple RTKs in hepatocellular carcinoma cells.
Author:	Ungerleider, Nathan\|Han, Chang\|Zhang, Jinqiang\|Yao, Lu\|Wu, Tong
PMID:	27862334

223.
Journal:	Oncotarget. 2017 Jan 3;8(1):915-932.
Title:	Non-toxic dose of liposomal honokiol suppresses metastasis of hepatocellular carcinoma through destabilizing EGFR and inhibiting the downstream pathways.
Author:	Yang, Jianhong\|Pei, Heying\|Luo, Hong\|Fu, Afu\|Yang, Hansuo\|Hu, Jia\|Zhao, Chengjian\|Chai, LuLu\|Chen, Xiang\|Shao, Ximing\|Wang, Chunyu\|Wu, Wenshuang\|Wan, Li\|Ye, Haoyu\|Qiu, Qiang\|Peng, Aihua\|Wei, Yuquan\|Yang, Li\|Chen, Lijuan
PMID:	27906672

224.
Journal:	Cancer Lett. 2017 Mar 1;388:73-84.
Title:	Neurotensin regulation induces overexpression and activation of EGFR in HCC and restores response to erlotinib and sorafenib.
Author:	Wu, Zherui\|Galmiche, Antoine\|Liu, Jin\|Stadler, Nicolas\|Wendum, Dominique\|Segal-Bendirdjian, Evelyne\|Paradis, Valerie\|Forgez, Patricia
PMID:	27914862

225.
Journal:	Cancer Lett. 2017 Mar 28;389:1-10.
Title:	CD133 confers cancer stem-like cell properties by stabilizing EGFR-AKT signaling in hepatocellular carcinoma.
Author:	Jang, Jae-Woo\|Song, Yeonhwa\|Kim, Se-Hyuk\|Kim, Jin-Sun\|Kim, Kang Mo\|Choi, Eun Kyung\|Kim, Joon\|Seo, Haeng Ran
PMID:	28034805

226.
Journal:	J Biol Chem. 2017 Feb 24;292(8):3186-3200.
Title:	Loss of N-Acetylgalactosaminyltransferase-4 Orchestrates Oncogenic MicroRNA-9 in Hepatocellular Carcinoma.
Author:	Liu, Yidong\|Liu, Haiou\|Yang, Liu\|Wu, Qian\|Liu, Weisi\|Fu, Qiang\|Zhang, Weijuan\|Zhang, Haijian\|Xu, Jiejie\|Gu, Jianxin
PMID:	28062574

227.
Journal:	Oncotarget. 2017 Feb 21;8(8):13909-13916.
Title:	Systematic analysis of molecular mechanisms for HCC metastasis via text mining approach.
Author:	Zhen, Cheng\|Zhu, Caizhong\|Chen, Haoyang\|Xiong, Yiru\|Tan, Junyuan\|Chen, Dong\|Li, Jin
PMID:	28108733

228.
Journal:	Oncogene. 2017 Jun 15;36(24):3464-3476.
Title:	The novel MKL target gene myoferlin modulates expansion and senescence of hepatocellular carcinoma.
Author:	Hermanns, C\|Hampl, V\|Holzer, K\|Aigner, A\|Penkava, J\|Frank, N\|Martin, D E\|Maier, K C\|Waldburger, N\|Roessler, S\|Goppelt-Struebe, M\|Akrap, I\|Thavamani, A\|Singer, S\|Nordheim, A\|Gudermann, T\|Muehlich, S
PMID:	28114277

229.
Journal:	Dig Liver Dis. 2017 May;49(5):530-534.
Title:	Long-term efficacy and safety of switching from lamivudine+adefovir to tenofovir disoproxil fumarate in virologically suppressed patients.
Author:	Fasano, Massimo\|Maggi, Paolo\|Leone, Armando\|Volpe, Anna\|Fiore, Jose Ramon\|Angarano, Gioacchino\|Santantonio, Teresa Antonia
PMID:	28179096

230.
Journal:	Neoplasma. 2017;64(3):358-366.
Title:	MicroRNA-1285 inhibits malignant biological behaviors of human pancreatic cancer cells by negative regulation of YAP1.
Author:	Huang, H\|Xiong, G\|Shen, P\|Cao, Z\|Zheng, L\|Zhang, T\|Zhao, Y
PMID:	28253715

231.
Journal:	Anticancer Agents Med Chem. 2017;17(10):1389-1400.
Title:	Synthesis, EGFR Inhibition and Anti-cancer Activity of New 3,6-dimethyl-1-phenyl-4-(substituted-methoxy)pyrazolo[3,4-d] pyrimidine Derivatives.
Author:	Bakr, Rania B\|Mehany, Ahmed B M\|Abdellatif, Khaled R A
PMID:	28270084

232.
Journal:	Eur J Med Chem. 2017 Apr 21;130:393-405.
Title:	Design, synthesis, and biological evaluation of novel 4-anilinoquinazoline derivatives bearing amino acid moiety as potential EGFR kinase inhibitors.
Author:	Zheng, You-Guang\|Su, Jun\|Gao, Cai-Yun\|Jiang, Ping\|An, Lin\|Xue, Yun-Sheng\|Gao, Jian\|Liu, Yi
PMID:	28279846

233.
Journal:	J Cancer Res Clin Oncol. 2017 Jul;143(7):1337-1346.
Title:	Incidence and outcomes of acute kidney injury in patients with hepatocellular carcinoma after liver transplantation.
Author:	Chen, Xiaohong\|Ding, Xiaoqiang\|Shen, Bo\|Teng, Jie\|Zou, Jianzhou\|Wang, Ting\|Zhou, Jian\|Chen, Nan\|Zhang, Boheng
PMID:	28289896

234.
Journal:	Oncotarget. 2017 Mar 21;8(12):19354-19364.
Title:	Secreted GRP78 activates EGFR-SRC-STAT3 signaling and confers the resistance to sorafeinib in HCC cells.
Author:	Li, Rui\|Yanjiao, Gu\|Wubin, He\|Yue, Wang\|Jianhua, Huang\|Huachuan, Zheng\|Rongjian, Su\|Zhidong, Luan
PMID:	28423613

235.
Journal:	Med Oncol. 2017 Jun;34(6):101.
Title:	The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
Author:	Zhang, Chaoyang\|Peng, Li\|Zhang, Yaqin\|Liu, Zhaoyang\|Li, Wenling\|Chen, Shilian\|Li, Guancheng
PMID:	28432618

236.
Journal:	Oncotarget. 2017 Apr 18;8(16):27263-27276.
Title:	SHP2 is induced by the HBx-NF-kappaB pathway and contributes to fibrosis during human early hepatocellular carcinoma development.
Author:	Kang, Hyo Jeong\|Chung, Dal-Hee\|Sung, Chang Ohk\|Yoo, Su Hyun\|Yu, Eunsil\|Kim, Nayoung\|Lee, Sy-Hye\|Song, Ji-Young\|Kim, Chong Jai\|Choi, Jene
PMID:	28460481

237.
Journal:	PLoS One. 2017 May 9;12(5):e0176562.
Title:	Genome and transcriptome profiling of fibrolamellar hepatocellular carcinoma demonstrates p53 and IGF2BP1 dysregulation.
Author:	Sorenson, Eric C\|Khanin, Raya\|Bamboat, Zubin M\|Cavnar, Michael J\|Kim, Teresa S\|Sadot, Eran\|Zeng, Shan\|Greer, Jonathan B\|Seifert, Adrian M\|Cohen, Noah A\|Crawley, Megan H\|Green, Benjamin L\|Klimstra, David S\|DeMatteo, Ronald P
PMID:	28486549

238.
Journal:	Bioorg Med Chem. 2017 Jun 15;25(12):2956-2970.
Title:	Design and synthesis of pyrazolo[3,4-d]pyrimidines: Nitric oxide releasing compounds targeting hepatocellular carcinoma.
Author:	Elshaier, Yaseen A M M\|Shaaban, Mohamed A\|Abd El Hamid, Mohammed K\|Abdelrahman, Mostafa H\|Abou-Salim, Mahrous A\|Elgazwi, Sara M\|Halaweish, Fathi
PMID:	28487127

239.
Journal:	Sci Rep. 2017 Jul 11;7(1):5134.
Title:	Hydrogen sulfide acts as a double-edged sword in human hepatocellular carcinoma cells through EGFR/ERK/MMP-2 and PTEN/AKT signaling pathways.
Author:	Wu, Dongdong\|Li, Mengling\|Tian, Wenke\|Wang, Shuaiwei\|Cui, Longzhen\|Li, Hui\|Wang, Huijuan\|Ji, Ailing\|Li, Yanzhang
PMID:	28698660

240.
Journal:	Sci Rep. 2017 Jul 19;7(1):5851.
Title:	Design and discovery of novel monastrol-1,3,5-triazines as potent anti-breast cancer agent via attenuating Epidermal Growth Factor Receptor tyrosine kinase.
Author:	Srivastava, Jitendra Kumar\|Pillai, Girinath G\|Bhat, Hans Raj\|Verma, Amita\|Singh, Udaya Pratap
PMID:	28724908

241.
Journal:	Oncol Res. 2017 Jul 21.
Title:	MicroRNA-374a Promotes Hepatocellular Carcinoma Cell Proliferation by Targeting Mitogen-Inducible Gene-6 (MIG-6).
Author:	Li, Hui\|Chen, Huicheng\|Wang, Haibin\|Dong, Yilong\|Yin, Min\|Zhang, Liang\|Wei, Jia
PMID:	28734040

242.
Journal:	Biomaterials. 2017 Oct;143:1-16.
Title:	Simultaneous inhibition of growth and metastasis of hepatocellular carcinoma by co-delivery of ursolic acid and sorafenib using lactobionic acid modified and pH-sensitive chitosan-conjugated mesoporous silica nanocomplex.
Author:	Zhao, Ruirui\|Li, Tao\|Zheng, Guirong\|Jiang, Kai\|Fan, Lulu\|Shao, Jingwei
PMID:	28755539

243.
Journal:	J Virol. 2017 Sep 27;91(20). pii: JVI.00467-17.
Title:	HRAS, EGFR, MET, and RON Genes Are Recurrently Activated by Provirus Insertion in Liver Tumors Induced by the Retrovirus Myeloblastosis-Associated Virus 2.
Author:	Pecenka, Vladimir\|Pajer, Petr\|Karafiat, Vit\|Kasparova, Petra\|Dudlova, Jana\|Dvorak, Michal
PMID:	28768863

244.
Journal:	Cancer Med. 2017 Sep;6(9):2042-2051.
Title:	INST OX-05-024: first line gemcitabine, oxaliplatin, and erlotinib for primary hepatocellular carcinoma and bile duct cancers: a multicenter Phase II trial.
Author:	Patt, Yehuda Z\|Murad, Waheed\|Fekrazad, Mohammed H\|Baron, Ari D\|Bansal, Pranshu\|Boumber, Yanis\|Steinberg, Kim\|Lee, Sang-Joon\|Bedrick, Ed\|Du, Ruofei\|Lee, Fa Chyi
PMID:	28801995

245.
Journal:	Mol Cancer. 2017 Sep 11;16(1):152.
Title:	Cell-specific mechanisms of TMEM16A Ca(2+)-activated chloride channel in cancer.
Author:	Wang, Hui\|Zou, Liang\|Ma, Ke\|Yu, Jiankun\|Wu, Huizhe\|Wei, Minjie\|Xiao, Qinghuan
PMID:	28893247

246.
Journal:	Sci Rep. 2017 Sep 13;7(1):11448.
Title:	MicroRNA pharmacogenomics based integrated model of miR-17-92 cluster in sorafenib resistant HCC cells reveals a strategy to forestall drug resistance.
Author:	Awan, Faryal Mehwish\|Naz, Anam\|Obaid, Ayesha\|Ikram, Aqsa\|Ali, Amjad\|Ahmad, Jamil\|Naveed, Abdul Khaliq\|Janjua, Hussnain Ahmed
PMID:	28904393

247.
Journal:	Sci Rep. 2017 Sep 14;7(1):11563.
Title:	Inhibition of fucosylation by 2-fluorofucose suppresses human liver cancer HepG2 cell proliferation and migration as well as tumor formation.
Author:	Zhou, Ying\|Fukuda, Tomohiko\|Hang, Qinglei\|Hou, Sicong\|Isaji, Tomoya\|Kameyama, Akihiko\|Gu, Jianguo
PMID:	28912543

248.
Journal:	Bioconjug Chem. 2017 Nov 15;28(11):2794-2803.
Title:	Ultrasmall Paramagnetic Iron Oxide Nanoprobe Targeting Epidermal Growth Factor Receptor for In Vivo Magnetic Resonance Imaging of Hepatocellular Carcinoma.
Author:	Chen, Yan\|Zhou, Quan\|Li, Xue\|Wang, Fa\|Heist, Kevin\|Kuick, Rork\|Owens, Scott R\|Wang, Thomas D
PMID:	28972742

249.
Journal:	BMC Complement Altern Med. 2017 Oct 4;17(1):477.
Title:	Resveratrol enhances anticancer effects of paclitaxel in HepG2 human liver cancer cells.
Author:	Jiang, Qin\|Yang, Manyi\|Qu, Zhan\|Zhou, Jixiang\|Zhang, Qi
PMID:	28978315

250.
Journal:	Pathologe. 2017 Nov;38(Suppl 2):211-217.
Title:	[Nuclear Her2 expression in hepatocytes in liver disease].
Author:	Doring, P\|Pilo, G M\|Calvisi, D F\|Dombrowski, F
PMID:	29018945

251.
Journal:	Front Med (Lausanne). 2017 Sep 28;4:164.
Title:	Hepatoid Adenocarcinoma of the Stomach: A Challenging Diagnostic and Therapeutic Disease through a Case Report and Review of the Literature.
Author:	Fakhruddin, Najla\|Bahmad, Hisham F\|Aridi, Tarek\|Yammine, Yara\|Mahfouz, Rami\|Boulos, Fouad\|Awada, Ahmad\|Farhat, Fadi
PMID:	29034239

252.
Journal:	Korean J Anesthesiol. 2017 Oct;70(5):527-534.
Title:	Effects of acute kidney injury after liver resection on long-term outcomes.
Author:	Ishikawa, Seiji\|Tanaka, Manami\|Maruyama, Fumi\|Fukagawa, Arisa\|Shiota, Nobuhiro\|Matsumura, Satoshi\|Makita, Koshi
PMID:	29046772

253.
Journal:	Oncotarget. 2017 May 3;8(42):71736-71749.
Title:	UBE2J2 promotes hepatocellular carcinoma cell epithelial-mesenchymal transition and invasion in vitro.
Author:	Chen, Shaopeng\|Tan, Ying\|Deng, Haihua\|Shen, Zhifa\|Liu, Yanhong\|Wu, Pan\|Tan, Chunyan\|Jiang, Yuyang
PMID:	29069742

254.
Journal:	Ann Surg Treat Res. 2017 Oct;93(4):173-180.
Title:	Establishing a colorectal cancer liver metastasis patient-derived tumor xenograft model for the evaluation of personalized chemotherapy.
Author:	Jung, Joohee\|Kim, Jisup\|Lim, Hyun Kyung\|Kim, Kyoung Mee\|Lee, Yun Sun\|Park, Joon Seong\|Yoon, Dong Sup
PMID:	29094026

255.
Journal:	Oncogene. 2017 Nov 30;36(48):6747-6748.
Title:	Reticulocalbin-2 enhances hepatocellular carcinoma proliferation via modulating the EGFR-ERK pathway.
Author:	Ding, D\|Huang, H\|Jiang, W\|Yu, W\|Zhu, H\|Liu, J\|Saiyin, H\|Wu, J\|Huang, H\|Jiang, S\|Yu, L
PMID:	29188822

256.
Journal:	Molecules. 2017 Dec 27;23(1). pii: molecules23010048.
Title:	Design, Synthesis and Cytotoxic Evaluation of Novel Chalcone Derivatives Bearing Triazolo[4,3-a]-quinoxaline Moieties as Potent Anticancer Agents with Dual EGFR Kinase and Tubulin Polymerization Inhibitory Effects.
Author:	Alswah, Mohamed\|Bayoumi, Ashraf H\|Elgamal, Kamal\|Elmorsy, Ahmed\|Ihmaid, Saleh\|Ahmed, Hany E A
PMID:	29280968

257.
Journal:	Technol Cancer Res Treat. 2017 Dec;16(6):1136-1149.
Title:	Mir-452-3p: A Potential Tumor Promoter That Targets the CPEB3/EGFR Axis in Human Hepatocellular Carcinoma.
Author:	Tang, Hui\|Zhang, Jianwen\|Yu, Zhenyu\|Ye, Linsen\|Li, Kun\|Ding, Fan\|Feng, Xiao\|Meng, Wei
PMID:	29332449

258.
Journal:	Curr Cancer Drug Targets. 2018;18(5):430-441.
Title:	The Role of Target Therapy in the Treatment of Gastrointestinal Noncolorectal Cancers: Clinical Impact and Cost Consideration.
Author:	Berretta, Massimiliano\|Romano, Carmela\|Di Francia, Raffaele\|De Diviitis, Chiara\|Canzonieri, Vincenzo\|Caraglia, Michele\|Facchini, Gaetano\|Nasti, Guglielmo
PMID:	28183250

259.
Journal:	Mol Carcinog. 2018 Jan;57(1):44-56.
Title:	Metformin incombination with curcumin inhibits the growth, metastasis, and angiogenesis of hepatocellular carcinoma in vitro and in vivo.
Author:	Zhang, Hui-Hui\|Zhang, Ying\|Cheng, Yan-Na\|Gong, Fu-Lian\|Cao, Zhan-Qi\|Yu, Lu-Gang\|Guo, Xiu-Li
PMID:	28833603

260.
Journal:	Int J Hyperthermia. 2018 Sep;34(6):812-823.
Title:	Heat stress induced, ligand-independent MET and EGFR signalling in hepatocellular carcinoma.
Author:	Thompson, Scott M\|Jondal, Danielle E\|Butters, Kim A\|Knudsen, Bruce E\|Anderson, Jill L\|Stokes, Matthew P\|Jia, Xiaoying\|Grande, Joseph P\|Roberts, Lewis R\|Callstrom, Matthew R\|Woodrum, David A
PMID:	28954551

261.
Journal:	Mol Carcinog. 2018 Feb;57(2):201-215.
Title:	Upregulation of UBE2Q1 via gene copy number gain in hepatocellular carcinoma promotes cancer progression through beta-catenin-EGFR-PI3K-Akt-mTOR signaling pathway.
Author:	Zhang, Bin\|Deng, Chao\|Wang, Lei\|Zhou, Fan\|Zhang, Shu\|Kang, Wei\|Zhan, Ping\|Chen, Juan\|Shen, Shanshan\|Guo, Huimin\|Zhang, Ming\|Wang, Yi\|Zhang, Feng\|Zhang, Wei\|Xiao, Jiangqiang\|Kong, Bo\|Friess, Helmut\|Zhuge, Yuzheng\|Yan, Hongli\|Zou, Xiaoping
PMID:	29027712

262.
Journal:	Int J Oncol. 2018 Jan;52(1):189-200.
Title:	Apoptosis in human liver carcinoma caused by gold nanoparticles in combination with carvedilol is mediated via modulation of MAPK/Akt/mTOR pathway and EGFR/FAAD proteins.
Author:	De Araujo, Raimundo F Jr\|Pessoa, Jonas B\|Cruz, Luis J\|Chan, Alan B\|De Castro Miguel, Emilio\|Cavalcante, Romulo S\|Brito, Gerly Anne C\|Silva, Heloiza Fernada O\|Gasparotto, Luiz H S\|Guedes, Paulo M M\|Araujo, Aurigena A
PMID:	29115423

263.
Journal:	Exp Mol Pathol. 2018 Apr;104(2):125-129.
Title:	Expression of proteins upregulated in hepatocellular carcinoma in patients with alcoholic hepatitis (AH) compared to non-alcoholic steatohepatitis (NASH): An immunohistochemical analysis of candidate proteins.
Author:	Lu, Jiajie George\|Nguyen, Luan\|Samadzadeh, Sara\|Masouminia, Maryam\|Mendoza, Alejandro\|Sweeney, Owen\|Tillman, Brittany\|Afifyan, Nikoo\|Morgan, Timothy\|French, Barbara A\|French, Samuel W
PMID:	29425759

264.
Journal:	N Biotechnol. 2018 Oct 25;45:113-122.
Title:	Neuregulin 1 discovered as a cleavage target for the HCV NS3/4A protease by a microfluidic membrane protein array.
Author:	Schwartz, Nika\|Pellach, Michal\|Glick, Yair\|Gil, Reuven\|Levy, Gahl\|Avrahami, Dorit\|Barbiro-Michaely, Efrat\|Nahmias, Yaakov\|Gerber, Doron
PMID:	29438748

265.
Journal:	Sci Rep. 2018 Feb 19;8(1):3287.
Title:	Common Deregulation of Seven Biological Processes by MicroRNAs in Gastrointestinal Cancers.
Author:	Zhang, Lin\|Zhang, Yuchen\|Wong, Sunny H\|Law, Priscilla T Y\|Zhao, Shan\|Yu, Jun\|Chan, Matthew T V\|Wu, William K K
PMID:	29459716

266.
Journal:	Steroids. 2018 Jun;134:78-87.
Title:	The ER-alpha36/EGFR signaling loop promotes growth of hepatocellular carcinoma cells.
Author:	You, Hui\|Meng, Kun\|Wang, Zhao-Yi
PMID:	29481815

267.
Journal:	Int J Mol Med. 2018 May;41(5):2813-2831.
Title:	Downregulated miR-23b-3p expression acts as a predictor of hepatocellular carcinoma progression: A study based on public data and RT-qPCR verification.
Author:	He, Rong-Quan\|Wu, Pei-Rong\|Xiang, Xue-Lian\|Yang, Xia\|Liang, Hai-Wei\|Qiu, Xiao-Hui\|Yang, Li-Hua\|Peng, Zhi-Gang\|Chen, Gang
PMID:	29484429

268.
Journal:	Oncologist. 2018 May;23(5):586-593.
Title:	Next-Generation Sequencing of Circulating Tumor DNA Reveals Frequent Alterations in Advanced Hepatocellular Carcinoma.
Author:	Ikeda, Sadakatsu\|Tsigelny, Igor F\|Skjevik, Age A\|Kono, Yuko\|Mendler, Michel\|Kuo, Alexander\|Sicklick, Jason K\|Heestand, Gregory\|Banks, Kimberly C\|Talasaz, AmirAli\|Lanman, Richard B\|Lippman, Scott\|Kurzrock, Razelle
PMID:	29487225

269.
Journal:	Clin Cancer Res. 2018 Jul 1;24(13):3204-3216.
Title:	COX-2/PGE2 Axis Regulates HIF2alpha Activity to Promote Hepatocellular Carcinoma Hypoxic Response and Reduce the Sensitivity of Sorafenib Treatment.
Author:	Dong, Xiao-Feng\|Liu, Tian-Qi\|Zhi, Xu-Ting\|Zou, Jie\|Zhong, Jing-Tao\|Li, Tao\|Mo, Xiang-Lan\|Zhou, Wei\|Guo, Wen-Wen\|Liu, Xia\|Chen, Yuan-Yuan\|Li, Meng-Yang\|Zhong, Xiao-Gang\|Han, Ya-Min\|Wang, Zhong-Hao\|Dong, Zhao-Ru
PMID:	29514844

270.
Journal:	Signal Transduct Target Ther. 2018 Jan 26;3:3.
Title:	The dual-inhibitory effect of miR-338-5p on the multidrug resistance and cell growth of hepatocellular carcinoma.
Author:	Zhao, Yang\|Chen, Jing\|Wei, Wenxin\|Qi, Xinming\|Li, Chunzhu\|Ren, Jin
PMID:	29527329

271.
Journal:	Mol Cell Biochem. 2018 Mar 12. pii: 10.1007/s11010-018-3341-9.
Title:	A novel matrine derivative WM622 inhibits hepatocellular carcinoma by inhibiting PI3K/AKT signaling pathways.
Author:	Sun, Xiao\|Zhuo, Xiao-Bin\|Hu, Yi-Ping\|Zheng, Xuan\|Zhao, Qing-Jie
PMID:	29532226

272.
Journal:	J Cell Mol Med. 2018 Jun;22(6):2981-2992.
Title:	Integrated transcriptomic and proteomic analyses reveal a-lipoic acid-regulated cell proliferation via Grb2-mediated signalling in hepatic cancer cells.
Author:	Yang, Lan\|Wang, Xiliang\|Xu, Juan\|Wen, Ya\|Zhang, Manqiao\|Lu, Jingxiao\|Wang, Rongfu\|Sun, Xiaojuan
PMID:	29575431

273.
Journal:	Cell Physiol Biochem. 2018;46(1):226-237.
Title:	The Effect of and Mechanism Underlying Autophagy in Hepatocellular Carcinoma Induced by CH12, a Monoclonal Antibody Directed Against Epidermal Growth Factor Receptor Variant III.
Author:	Xu, Wen\|Song, Fei\|Wang, Biao\|Li, Kesang\|Tian, Mi\|Yu, Min\|Pan, Xiaorong\|Shi, Bizhi\|Liu, Jianwen\|Gu, Jianren\|Li, Zonghai\|Jiang, Hua
PMID:	29587298

274.
Journal:	Oncogene. 2018 Jul;37(28):3894-3908.
Title:	An EGFR ligand promotes EGFR-mutant but not KRAS-mutant lung cancer in vivo.
Author:	Tomoshige, Koichi\|Guo, Minzhe\|Tsuchiya, Tomoshi\|Fukazawa, Takuya\|Fink-Baldauf, Iris M\|Stuart, William D\|Naomoto, Yoshio\|Nagayasu, Takeshi\|Maeda, Yutaka
PMID:	29662194

275.
Journal:	Anticancer Agents Med Chem. 2018 May 7. pii: ACAMC-EPUB-90231.
Title:	HCC Specific Protein Network Involving Interactions of EGFR with A-Raf and Transthyretin: Experimental Analysis and Computational Biology Correlates.
Author:	Ranjpour, Maryam\|Katare, Deepshikha Pande\|Wajid, Saima\|Jain, Swatantra Kumar
PMID:	29732980

276.
Journal:	Mol Ther Nucleic Acids. 2018 Jun 1;11:494-507.
Title:	miR372 Promotes Progression of Liver Cancer Cells by Upregulating erbB-2 through Enhancement of YB-1.
Author:	Lin, Zhuojia\|Lu, Yanan\|Meng, Qiuyu\|Wang, Chen\|Li, Xiaonan\|Yang, Yuxin\|Xin, Xiaoru\|Zheng, Qidi\|Xu, Jie\|Gui, Xin\|Li, Tianming\|Pu, Hu\|Xiong, Wujun\|Li, Jiao\|Jia, Song\|Lu, Dongdong
PMID:	29858084

277.
Journal:	Environ Toxicol. 2018 Jun 19.
Title:	The protective mechanism of Nigella sativa against diethylnitrosamine-induced hepatocellular carcinoma through its antioxidant effect and EGFR/ERK1/2 signaling.
Author:	Shahin, Y R\|Elguindy, N M\|Abdel Bary, A\|Balbaa, M
PMID:	29923357

278.
Journal:	J Hepatol. 2018 Oct;69(4):840-850.
Title:	Mutational landscape of a chemically-induced mouse model of liver cancer.
Author:	Connor, Frances\|Rayner, Tim F\|Aitken, Sarah J\|Feig, Christine\|Lukk, Margus\|Santoyo-Lopez, Javier\|Odom, Duncan T
PMID:	29958939

279.
Journal:	Can J Physiol Pharmacol. 2018 Aug 8.
Title:	Silencing non-SMC chromosome-associated polypeptide G inhibits proliferation and induces apoptosis in hepatocellular carcinoma cells.
Author:	Liu, Kaikun\|Li, Yumin\|Yu, Bo\|Wang, Furong\|Mi, Taiyu\|Zhao, Yongxun
PMID:	30089216

280.
Journal:	Ann Transl Med. 2018 Jul;6(14):285.
Title:	Precision oncology in liver cancer.
Author:	Sullivan, Kevin M\|Kenerson, Heidi L\|Pillarisetty, Venu G\|Riehle, Kimberly J\|Yeung, Raymond S
PMID:	30105235

281.
Journal:	Liver Int. 2018 Sep 4.
Title:	P57-mediated autophagy promotes the efficacy of EGFR inhibitors in hepatocellular carcinoma.
Author:	Li, Wen-Yuan\|Li, Qing\|Jing, Li\|Wu, Tao\|Han, Li-Li\|Wang, Yu\|Yu, Si-Zhe\|Nan, Ke-Jun\|Guo, Hui
PMID:	30178471

282.
Journal:	J Cell Physiol. 2018 Sep 10.
Title:	Neratinib augments the lethality of [regorafenib + sildenafil].
Author:	Booth, Laurence\|Roberts, Jane L\|Rais, Rumeesa\|Cutler, Richard E Jr\|Diala, Irmina\|Lalani, Alshad S\|Hancock, John F\|Poklepovic, Andrew\|Dent, Paul
PMID:	30203445

283.
Journal:	Breast Cancer Res. 2018 Sep 12;20(1):112.
Title:	Nogo-B receptor increases the resistance to tamoxifen in estrogen receptor-positive breast cancer cells.
Author:	Gao, Pin\|Wang, Xiang\|Jin, Ying\|Hu, Wenquan\|Duan, Yajun\|Shi, Aiping\|Du, Ye\|Song, Dong\|Yang, Ming\|Li, Sijie\|Han, Bing\|Zhao, Gang\|Zhang, Hongquan\|Fan, Zhimin\|Miao, Qing Robert
PMID:	30208932

284.
Journal:	Oncol Rep. 2018 Oct 1.
Title:	Capsaicin and sorafenib combination treatment exerts synergistic antihepatocellular carcinoma activity by suppressing EGFR and PI3K/Akt/mTOR signaling.
Author:	Dai, Ninggao\|Ye, Ruifan\|He, Qikuan\|Guo, Pengyi\|Chen, Hao\|Zhang, Qiyu
PMID:	30272354

285.
Journal:	J Enzyme Inhib Med Chem. 2018 Dec;33(1):1516-1528.
Title:	Benzofuran-appended 4-aminoquinazoline hybrids as epidermal growth factor receptor tyrosine kinase inhibitors: synthesis, biological evaluation and molecular docking studies.
Author:	Mphahlele, Malose J\|Maluleka, Marole M\|Aro, Abimbola\|McGaw, Lyndy J\|Choong, Yee Siew
PMID:	30274538

286.
Journal:	Bioorg Med Chem Lett. 2018 Oct 11. pii: S0960-894X(18)30806-0.
Title:	Design, synthesis and evaluation of novel hybrids between 4-anilinoquinazolines and substituted triazoles as potent cytotoxic agents.
Author:	Le-Nhat-Thuy, Giang\|Dinh, Thuy Van\|Pham-The, Hai\|Nguyen Quang, Hung\|Nguyen Thi, Nga\|Dang Thi, Tuyet Anh\|Hoang Thi, Phuong\|Le Thi, Tu Anh\|Nguyen, Ha Thanh\|Nguyen Thanh, Phuong\|Le Duc, Trung\|Nguyen, Tuyen Van
PMID:	30337229

287.
Journal:	Oncotarget. 2018 Sep 28;9(76):34279-34288.
Title:	Spatio-temporal tumor heterogeneity in metastatic CRC tumors: a mutational-based approach.
Author:	Del Carmen, Sofia\|Sayagues, Jose Maria\|Bengoechea, Oscar\|Anduaga, Maria Fernanda\|Alcazar, Jose Antonio\|Gervas, Ruth\|Garcia, Jacinto\|Orfao, Alberto\|Bellvis, Luis Munoz\|Sarasquete, Maria Eugenia\|Del Mar Abad, Maria
PMID:	30344942

288.
Journal:	Nanomedicine. 2018 Oct 21. pii: S1549-9634(18)30537-9.
Title:	Smart nanoparticles assembled by endogenous molecules for siRNA delivery and cancer therapy via CD44 and EGFR dual-targeting.
Author:	Liang, Yaoyao\|Peng, Jiahui\|Li, Ning\|Yu-Wai-Man, Cynthia\|Wang, Qian\|Xu, Yuhong\|Wang, Hongxia\|Tagalakis, Aristides D\|Du, Zixiu
PMID:	30352311